Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3028308	pf-eryt	e6/l (e6/l)	2332	3256	0.00%
3028308	pf-eryt	— (—)	1789	2419	100.00%	Distribution not available
3028308	pf-erytrosyytit	e6/l (e6/l)	11	14	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Asthma, excluding more controls

493

239

11.09

319.09

1.5

1.2

52037.94

53101.20

e6/l

0.02

293

121

Heart failure and antihypertensive medication

523

440

8.14

314.09

1.6

1.4

40287.64

55039.31

e6/l

0.47

333

266

Other medical care

742

1584

4.71

310.84

1.5

71464.45

57266.18

e6/l

0.42

458

948

1328

1654

5.13

307.65

1.5

1.4

39441.98

51447.46

e6/l

0.85

813

956

Asthma, unspecified (mode), excluding more controls

402

225

14.20

307.65

1.5

1.2

46425.67

49911.70

e6/l

0.09

242

115

Pneumonias (Asthma/COPD co-morbidities)

1447

1968

5.19

307.65

1.5

1.4

40865.78

59727.21

e6/l

1.54

881

1156

Other bacterial diseases

1292

2295

3.96

307.65

1.5

1.4

55563.67

56806.62

e6/l

0.04

784

1354

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1328

1654

5.13

307.65

1.5

1.4

39441.98

51447.46

e6/l

0.85

813

956

Heart failure,strict

1128

1219

6.94

307.65

1.6

1.4

57756.86

66124.24

e6/l

0.26

684

735

All-cause Heart Failure

1185

1601

5.53

307.65

1.5

1.4

56563.56

65248.16

e6/l

0.31

719

965

Heart failure, strict

1226

1630

5.62

307.65

1.5

1.4

54850.52

64560.64

e6/l

0.37

747

985

Other pleural conditions

925

256

46.43

307.65

1.8

1.2

69646.13

21786.71

e6/l

4.07

640

144

Heart failure, not strict

1260

1563

5.71

307.65

1.6

1.4

46994.52

61249.53

e6/l

0.77

766

937

ILD differential diagnosis

755

436

8.78

307.65

1.5

1.2

58131.48

35213.24

e6/l

0.97

451

222

Dyspnoea

1222

2526

3.77

307.65

1.6

1.4

55044.24

56366.90

e6/l

0.05

790

1468

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

564

684

7.25

307.65

1.4

1.5

72936.87

67198.33

e6/l

0.10

349

409

Excluding asthma or asthma-COPD overlap

757

436

8.80

307.65

1.5

1.2

57984.50

35464.63

e6/l

0.95

452

220

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

711

1195

5.38

307.65

1.4

1.5

47874.67

57979.84

e6/l

0.41

437

725

Suppurative and necrotic conditions of lower respiratory tract

360

206

21.06

307.65

1.6

1.4

44882.48

75147.92

e6/l

0.68

231

121

Other pulmonary diagnosis

771

436

8.96

307.65

1.5

1.2

58194.95

35464.63

e6/l

0.99

468

220

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1442

1993

5.18

307.65

1.5

1.4

43604.61

59160.24

e6/l

1.13

880

1175

Other diseases of pleura

2226

1065

20.56

307.65

1.6

1.2

68835.72

33350.85

e6/l

4.37

1462

559

Pleural effusion

1624

387

56.12

307.65

1.7

1.3

67522.15

25447.14

e6/l

4.82

1063

204

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

452

528

8.58

307.65

1.4

1.5

65496.35

70833.19

e6/l

0.08

279

314

Lung cancer and mesothelioma

677

228

27.41

307.65

1.5

1.2

60669.85

23492.31

e6/l

1.92

443

111

COPD differential diagnosis

755

436

8.78

307.65

1.5

1.2

58131.48

35213.24

e6/l

0.97

451

222

COPD (mode)

446

315

11.54

307.65

1.4

1.2

71245.96

32795.08

e6/l

1.03

286

159

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

716

776

8.21

307.65

1.5

73332.55

62654.21

e6/l

0.24

466

468

Bacterial infection, other or unspecified

917

1855

4.58

307.65

1.6

1.4

55516.56

60676.66

e6/l

0.18

580

1107

All pneumoniae

1448

1960

5.20

307.65

1.5

1.4

38694.33

59704.94

e6/l

1.89

880

1153

Pneumonia, organism unspecified

1376

1879

5.41

307.65

1.5

1.4

44348.33

60037.74

e6/l

1.07

861

1103

Influenza and pneumonia

1448

1910

5.07

307.65

1.5

1.4

38685.30

60054.02

e6/l

1.89

880

1121

Pyothorax

333

169

24.96

307.65

1.6

1.4

46651.57

79933.05

e6/l

0.60

212

Malignant neoplasm of respiratory system and intrathoracic organs

606

1038

5.67

301.65

1.5

61735.58

67385.64

e6/l

0.13

418

605

Non-ischemic cardiomyopathy

608

918

5.65

292.03

1.5

1.4

55946.01

64597.25

e6/l

0.20

359

554

Asthma (only as main-diagnosis), excluding more controls

419

239

10.53

283.50

1.5

1.2

55224.75

53101.20

e6/l

0.05

251

121

Asthma, unspecified (mode)

421

411

8.21

283.48

1.5

1.2

46039.41

33849.52

e6/l

0.55

252

210

Renal tubulo-interstitial diseases

1093

2502

3.40

275.64

1.5

1.4

50692.51

59311.07

e6/l

0.40

652

1503

Abnormal findings on diagnostic imaging of lung

829

2122

3.91

271.93

1.5

1.4

69464.08

57806.36

e6/l

0.39

533

1260

Renal failure

828

1972

3.96

270.37

1.6

1.4

39949.13

67079.33

e6/l

1.88

505

1198

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

949

2535

3.54

267.37

1.6

1.4

67688.40

54754.43

e6/l

0.51

605

1501

Persons encountering health services for specific procedures and health care

1178

2275

3.25

258.98

1.5

1.4

50511.51

55733.67

e6/l

0.24

712

1354

Oxycodone

636

1386

4.57

255.90

1.5

1.4

48837.89

54363.31

e6/l

0.20

416

816

Later onset COPD, excluding more controls

329

260

10.19

253.70

1.5

1.2

52598.52

21359.16

e6/l

1.81

211

129

Non-small cell lung cancer

452

794

6.03

247.02

1.4

1.5

65496.35

78224.30

e6/l

0.22

279

456

Heart failure and bmi 25plus

594

815

5.18

244.18

1.5

78871.78

70369.46

e6/l

0.16

353

491

Asthma

519

432

6.50

237.05

1.5

1.2

53286.13

35464.63

e6/l

0.80

311

220

Bacterial Sepsis

745

1751

3.88

236.32

1.6

1.4

54881.76

63881.46

e6/l

0.33

473

1076

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

149

38.50

232.67

1.9

1.5

53613.90

159592.81

e6/l

0.43

113

Diseases of the respiratory system

537

427

6.36

232.12

1.5

1.2

70499.79

28314.65

e6/l

1.66

317

218

Abnormalities of breathing

977

1714

3.43

229.95

1.6

1.4

55879.39

49349.31

e6/l

0.26

614

978

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1112

2659

3.04

229.59

1.5

60022.27

54352.26

e6/l

0.21

665

1600

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

227

191

13.08

228.71

1.5

69719.22

77203.59

e6/l

0.07

152

115

Mesothelioma, excluding all cancers (controls excluding all cancers)

139

47.39

226.02

2.0

1.4

41882.15

57698.52

e6/l

0.14

102

Dialysis, with operation codes

320

432

7.83

224.95

1.7

1.4

37558.94

77390.92

e6/l

1.11

213

267

Implicit Sepsis

932

2268

3.25

219.30

1.5

1.4

56926.59

59478.53

e6/l

0.08

581

1357

Other heart diseases, wide

826

1431

3.62

213.76

1.5

1.4

49228.50

50891.42

e6/l

0.05

491

868

Other heart diseases

457

518

5.90

212.67

1.5

1.3

63759.48

52265.40

e6/l

0.26

277

321

Implicit bacterial Sepsis

667

1627

3.86

211.57

1.6

1.4

53395.55

65872.30

e6/l

0.47

424

997

Valvular heart disease excluding rheumatic fever

608

1042

4.35

210.96

1.6

1.4

49335.58

57932.13

e6/l

0.36

376

645

Asthma (mode)

479

436

6.08

209.63

1.5

1.2

59267.26

35213.24

e6/l

1.11

289

222

Septicaemia

634

1592

3.92

209.03

1.6

1.4

53806.17

65089.13

e6/l

0.39

391

961

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

208

177

12.70

207.48

1.8

1.5

37988.55

78525.58

e6/l

0.53

139

102

Asthma (only as main-diagnosis)

442

432

6.22

207.07

1.5

1.2

53958.22

35464.63

e6/l

0.80

263

220

Non-rheumatic valve diseases

602

1038

4.31

206.99

1.6

1.4

49155.43

58221.20

e6/l

0.39

373

641

Malignant neoplasm of heart, mediastinum and pleura

133

39.79

204.91

2.0

1.3

40200.85

27635.48

e6/l

0.44

107

Mesothelioma

139

34.80

204.85

2.0

1.3

41882.15

151688.88

e6/l

0.85

102

Anaemias

217

18.07

204.22

1.6

1.4

42736.60

56969.88

e6/l

0.17

125

Bacterial pneumoniae

561

1200

4.22

200.27

1.5

1.4

59849.60

73901.52

e6/l

0.33

331

704

Explicit Sepsis

644

1680

3.76

199.94

1.6

1.4

53047.32

63473.49

e6/l

0.37

398

1025

Nephropathy related operations

303

443

7.23

198.31

1.6

1.4

45816.15

77762.35

e6/l

0.73

197

270

Bacterial pneumonia, not elsewhere classified

544

1156

4.25

195.84

1.5

1.4

60714.60

76398.88

e6/l

0.36

319

672

Acute renal failure

427

876

5.08

195.58

1.6

1.4

38965.02

69104.97

e6/l

1.21

264

519

Other diseases of pericardium

151

18.15

183.24

1.6

1.2

59472.07

65228.70

e6/l

0.05

102

Chronic kidney disease

551

1444

3.92

182.04

1.6

1.4

33373.77

69048.12

e6/l

2.48

340

873

Continuous positive airway pressure

311

416

6.63

180.06

1.5

1.4

53699.84

59866.84

e6/l

0.12

225

253

Other septicaemia

560

1469

3.83

179.72

1.6

1.4

48683.34

64963.71

e6/l

0.59

345

880

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

823

1512

3.25

179.10

1.4

1.5

51116.81

55288.81

e6/l

0.14

477

914

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

823

1512

3.25

179.08

1.4

1.5

51116.81

55288.81

e6/l

0.14

477

914

Malignant neoplasm, wide definition for exclusion

823

1513

3.25

178.91

1.4

1.5

51116.81

55288.81

e6/l

0.14

477

914

Malignant neoplasm of bronchus and lung

454

977

4.54

177.35

1.4

1.5

65710.35

72477.43

e6/l

0.12

301

563

COPD/asthma related infections

974

1654

2.98

173.68

1.5

1.4

49907.91

51447.46

e6/l

0.05

594

956

COPD/asthma/ILD related infections

974

1654

2.98

173.68

1.5

1.4

49907.91

51447.46

e6/l

0.05

594

956

Non-small cell lung cancer, adenocarcinoma

227

284

8.76

171.66

1.5

1.4

69719.22

89769.64

e6/l

0.25

152

165

Non-small cell lung cancer, adenocarcinoma, helper endpoint

227

284

8.76

171.66

1.5

1.4

69719.22

89769.64

e6/l

0.25

152

165

Malignant neoplasm

842

1633

3.09

169.39

1.4

1.5

46708.38

58837.07

e6/l

0.61

501

969

Condition for Implicit Sepsis (Organ dysfunction codes)

910

2348

2.85

169.18

1.5

1.4

59310.60

56801.11

e6/l

0.08

563

1403

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

300

516

6.03

166.74

1.3

1.5

61644.94

59972.33

e6/l

0.03

175

296

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

358

734

5.03

163.67

1.3

1.5

33908.15

63109.93

e6/l

1.37

229

430

Any gastric operation

645

878

3.71

159.81

1.5

1.4

55282.69

46677.57

e6/l

0.25

390

494

GASTRO-related operations

645

878

3.71

159.81

1.5

1.4

55282.69

46677.57

e6/l

0.25

390

494

Early onset COPD, excluding more controls

193

215

9.13

157.53

1.4

1.2

95454.23

47743.10

e6/l

0.48

120

109

Cardiomyopathy

283

490

5.95

155.98

1.5

1.3

28879.51

63964.49

e6/l

1.98

171

298

Atrial fibrillation and flutter

354

423

5.55

154.31

1.5

1.3

65253.24

59882.92

e6/l

0.09

217

266

Malignant neoplasm of mesothelium and soft tissue

175

183

10.64

152.56

1.8

1.4

38445.05

99019.46

e6/l

0.90

122

112

Care involving dialysis

188

223

8.92

147.39

1.7

1.4

37519.46

93165.53

e6/l

0.93

117

133

Any event in cancer register

806

1669

2.89

145.24

1.4

1.5

47335.49

58474.10

e6/l

0.53

488

977

Atrial fibrillation and flutter with reimbursement

322

374

5.62

140.81

1.5

1.3

55328.13

57925.75

e6/l

0.04

193

236

Fever of other and unknown origin

603

1849

3.06

135.80

1.5

1.4

68086.08

49730.12

e6/l

0.49

379

1087

Diseases of arteries, arterioles and capillaries (FINNGEN)

288

358

5.73

133.34

1.5

1.3

47865.99

56214.71

e6/l

0.17

168

229

Pneumothorax

139

141

10.32

122.49

1.6

1.2

64903.20

12625.74

e6/l

1.50

Cardiomyopathy (excluding other)

208

341

6.30

121.42

1.5

1.3

30527.84

77730.40

e6/l

1.63

134

198

Ascites

181

263

7.29

119.39

1.5

1.4

30696.85

82293.38

e6/l

1.02

112

159

Aplastic and other anaemias

613

2102

2.82

118.62

1.5

59772.89

59305.95

e6/l

0.01

354

1277

First line medication for Crohn's disease

988

2294

2.37

118.17

1.5

1.4

51162.44

57525.97

e6/l

0.28

595

1366

Bacterial pneumonia (organism specified)

586

1879

2.89

117.96

1.5

57772.03

63430.59

e6/l

0.13

349

1127

Cardiomyopathies, Primary/intrinsic

202

334

6.25

116.93

1.5

1.3

30876.56

69503.76

e6/l

1.33

131

194

Heart failure and coronary heart disease

571

1466

2.98

114.29

1.5

58931.09

62635.44

e6/l

0.09

361

872

Cardiac arrhythmias

463

915

3.37

111.25

1.5

1.4

60618.19

56161.02

e6/l

0.08

278

547

Valvular operations

213

415

5.28

103.41

1.5

1.3

65638.06

65334.77

e6/l

0.00

136

252

Erysipelas

573

1969

2.69

101.38

1.5

1.4

63527.95

61360.29

e6/l

0.06

346

1168

Other and unspecified anaemias

550

1984

2.73

100.90

1.5

63530.20

60563.48

e6/l

0.06

314

1204

Other anaemias

554

2003

2.72

100.60

1.5

63142.99

60318.00

e6/l

0.06

316

1216

Malaise and fatigue

536

1621

2.79

99.75

1.5

1.4

74514.15

51235.54

e6/l

0.63

337

949

Primary_lymphoid and hematopoietic malignant neoplasms

292

765

3.90

97.14

1.6

1.5

84437.02

59911.14

e6/l

0.35

180

449

Presence of cardiac and vascular implants and grafts

613

1832

2.58

94.77

1.5

66722.28

60044.91

e6/l

0.17

380

1107

Non-allergic asthma (mode), excluding more controls

107

106

10.10

94.17

1.6

1.2

95858.32

41184.37

e6/l

0.67

Extracorporeal dialysis

144

213

7.17

93.53

1.7

1.4

45594.88

90682.25

e6/l

0.66

130

ILD medications: prednisolone, methylprednisolone, prednisone

954

2532

2.14

91.90

1.6

1.4

52986.96

55552.67

e6/l

0.09

575

1526

Tramadol

678

1798

2.44

91.17

1.6

1.4

54831.64

54867.95

e6/l

0.00

411

1050

Certain infectious and parasitic diseases

798

1722

2.34

90.68

1.5

1.4

44820.06

60081.76

e6/l

0.76

471

1012

Oral corticosteroids

938

2694

2.12

89.65

1.6

1.4

58166.94

56624.75

e6/l

0.05

575

1617

Non-invasive ventilation

214

436

4.68

89.43

1.5

1.4

81173.55

62825.94

e6/l

0.18

255

AV-block

230

477

4.48

89.41

1.6

1.4

33689.37

67603.05

e6/l

1.60

144

294

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

811

2499

2.22

89.36

1.5

66276.80

53750.47

e6/l

0.47

511

1490

Benign neoplasm of colon, rectum, anus and anal canal

465

1160

2.89

89.07

1.5

66988.06

56428.48

e6/l

0.25

269

706

Bleeding

818

2737

2.19

88.64

1.5

75488.30

51894.78

e6/l

0.92

494

1643

Complications of surgical and medical care, not elsewhere classified

873

2951

2.14

88.57

1.5

71180.63

51170.10

e6/l

0.80

518

1777

Glomerular disorders in diseases classified elsewhere

203

435

4.83

88.48

1.6

1.4

32317.84

79801.83

e6/l

1.50

120

268

Diseases of arteries, arterioles and capillaries

747

2486

2.27

87.91

1.5

60415.49

57956.14

e6/l

0.07

446

1500

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

183

353

5.20

87.42

1.3

1.5

29163.51

47921.69

e6/l

0.45

207

Conduction disorders

307

723

3.58

86.42

1.6

1.4

29525.22

57864.30

e6/l

2.06

189

451

Cardiovascular diseases (excluding rheumatic etc)

340

547

3.61

86.28

1.5

1.3

57312.65

51509.96

e6/l

0.10

193

335

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

10.37

86.24

1.2

1.5

19542.64

89520.59

e6/l

0.54

Glomerular diseases

266

718

3.80

85.12

1.6

1.5

56908.96

66241.80

e6/l

0.11

157

433

Benign neoplasm: Colon

429

1140

2.92

84.93

1.5

65820.53

57645.46

e6/l

0.18

254

690

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

194

415

4.80

84.48

1.5

37802.42

61222.42

e6/l

0.49

120

242

ILD medications

953

2541

2.07

83.67

1.6

1.4

51560.19

55408.90

e6/l

0.16

566

1530

L01XE Protein kinase inhibitors

134

207

6.87

83.61

1.4

126318.25

114817.92

e6/l

0.06

118

COPD

571

1931

2.48

83.31

1.4

1.5

63969.06

58151.22

e6/l

0.12

358

1165

Other disorders of fluid, electrolyte and acid-base balance

386

1276

2.97

83.00

1.6

1.4

51181.65

49820.15

e6/l

0.04

249

755

Hypertensive heart and/or renal disease

366

920

3.15

81.98

1.5

1.4

31927.76

63250.17

e6/l

1.65

226

571

Haemorrhage from respiratory passages

394

1281

2.90

80.55

1.5

1.4

82762.97

51055.65

e6/l

0.62

237

736

Unspecified kidney failure

186

402

4.81

80.38

1.6

1.4

60512.42

68947.59

e6/l

0.11

110

249

Other chronic obstructive pulmonary disease

551

1883

2.47

80.15

1.4

1.5

66410.76

58841.80

e6/l

0.16

348

1142

Pericarditis

13.05

80.06

1.4

1.3

36251.89

71508.41

e6/l

0.39

Inflammatory bowel disease treatment related agents

956

2713

2.01

78.66

1.6

1.4

54914.53

56592.43

e6/l

0.06

567

1625

Opioids

769

1837

2.21

78.45

1.5

1.4

69548.40

54214.11

e6/l

0.51

454

1072

General symptoms and signs

870

2079

2.11

78.08

1.5

1.4

52190.93

49427.66

e6/l

0.09

538

1219

Diabetic nephropathy, excluding more controls

220

445

4.25

77.50

1.6

1.5

32449.72

47017.81

e6/l

0.60

141

247

Pulmonary heart disease, diseases of pulmonary circulation

405

1491

2.76

76.89

1.4

1.5

52326.75

60707.93

e6/l

0.25

244

885

Metabolic disorders

816

2444

2.09

75.59

1.5

54322.73

52519.31

e6/l

0.06

478

1477

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

15.73

74.85

1.4

19962.12

166009.00

e6/l

0.44

Other chronic obstructive pulmonary disease, including avohilmo

616

2288

2.27

74.24

1.4

1.5

68321.85

60296.16

e6/l

0.19

393

1370

Cerebrovascular diseases (FINNGEN)

236

427

3.99

74.06

1.6

1.3

35427.60

60011.92

e6/l

0.94

146

266

Transplanted organ and tissue status

144

268

5.54

73.76

1.6

1.4

49357.49

87058.76

e6/l

0.45

146

Acute tubulo-interstitial nephritis

555

2126

2.34

73.05

1.5

1.4

59465.99

59656.04

e6/l

0.00

326

1278

Dental caries

288

897

3.23

72.29

1.6

1.4

73128.86

49001.71

e6/l

0.32

176

529

Implicit viral Sepsis

237

663

3.65

71.89

1.6

1.4

45112.22

65845.40

e6/l

0.44

141

395

Viral Sepsis

237

663

3.65

71.88

1.6

1.4

45112.22

65845.40

e6/l

0.44

141

395

Hypertensive diseases (excluding secondary)

303

517

3.43

71.72

1.6

1.3

45379.87

52564.60

e6/l

0.17

181

318

Other arrhythmias

441

1300

2.62

71.65

1.5

1.4

57207.99

54140.10

e6/l

0.07

255

794

Ulcer of lower limb, not elsewhere classified

227

621

3.77

71.49

1.6

1.4

44574.93

54172.14

e6/l

0.25

134

374

Neoplasms

484

995

2.62

71.40

1.4

81574.07

57312.20

e6/l

0.57

279

611

COPD, early/later onset

561

2078

2.31

70.82

1.4

1.5

65468.38

60731.33

e6/l

0.10

354

1252

Pacemaker

454

1787

2.52

70.77

1.5

33135.54

67636.40

e6/l

3.04

266

1069

Dentinal caries

265

800

3.35

70.66

1.6

1.4

80291.61

49238.66

e6/l

0.39

158

476

Complications of procedures, not elsewhere classified

695

2876

2.10

70.57

1.5

78020.29

50206.04

e6/l

1.04

429

1727

COPD, hospital admissions

555

2065

2.31

69.79

1.4

1.5

66312.71

60649.06

e6/l

0.12

349

1245

Symptoms and signs involving the circulatory and respiratory systems

729

1715

2.14

68.16

1.5

1.4

64992.74

49349.31

e6/l

0.57

457

978

Any reimbursement code in KELA

272

368

3.72

68.12

1.5

1.4

63045.59

59518.05

e6/l

0.04

155

217

Respiratory insufficiency

110

8.26

66.97

1.3

153225.64

35044.30

e6/l

0.96

All influenza

232

679

3.46

65.52

1.6

1.4

40176.15

82032.72

e6/l

1.43

149

396

Pulmonary embolism

356

1333

2.72

65.48

1.5

56991.67

64254.99

e6/l

0.18

214

792

Paroxysmal tachycardia

175

343

4.36

65.12

1.5

1.3

26907.17

57104.23

e6/l

1.33

115

220

Pulmonary heart disease

356

1343

2.70

64.54

1.5

56991.67

63598.17

e6/l

0.16

214

798

Peripheral artery disease

545

1987

2.24

63.24

1.5

60906.06

57149.58

e6/l

0.09

328

1216

COPD related to multimorbidity

496

1841

2.30

62.06

1.4

1.5

54075.06

58980.69

e6/l

0.13

311

1104

Hypertensive Heart Disease

310

887

2.91

61.94

1.5

1.4

34916.70

62347.23

e6/l

1.21

191

547

Adjustment and management of implanted device

251

816

3.14

60.06

1.5

35693.26

63042.56

e6/l

1.31

133

481

Venous thromboembolism

552

2526

2.14

60.00

1.5

57609.36

55395.84

e6/l

0.07

332

1508

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

385

1190

2.55

59.57

1.4

1.5

76314.70

59080.13

e6/l

0.30

237

720

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

253

503

3.31

59.30

1.4

31740.00

41785.63

e6/l

0.27

142

287

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

253

503

3.31

59.29

1.4

31740.00

41785.63

e6/l

0.27

142

287

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

255

494

3.29

58.79

1.5

1.3

49687.85

54335.29

e6/l

0.09

149

303

Asthma-related pneumonia

395

1635

2.44

58.77

1.5

61052.98

58089.77

e6/l

0.07

232

973

Asthma-related pneumonia or sepsis

395

1637

2.44

58.61

1.5

61052.98

58089.77

e6/l

0.07

232

973

Asthma, hospital admissions 3, pneumonia

395

1637

2.44

58.61

1.5

61052.98

58089.77

e6/l

0.07

232

973

DVT of lower extremities and pulmonary embolism

457

2015

2.29

58.56

1.4

1.5

57874.72

57655.89

e6/l

0.01

272

1203

Viral pneumonia

137

300

4.66

58.03

1.6

1.3

42347.13

93435.82

e6/l

0.96

171

Complications of medical and surgical care

627

2985

2.01

57.33

1.5

81957.27

50008.00

e6/l

1.00

352

1817

Cardiomyopathy, other and unspecified

106

188

5.80

57.23

1.5

1.3

31727.13

92981.47

e6/l

1.24

109

Other CVD (FINNGEN)

128

196

5.25

57.14

1.6

1.3

31691.23

64457.98

e6/l

0.76

125

Infections, IBD-co-morbidities

194

378

3.80

57.11

1.6

1.4

40156.11

34693.31

e6/l

0.14

120

213

Explicit bacterial Sepsis

142

325

4.48

57.02

1.6

1.4

82252.83

83660.07

e6/l

0.01

197

Atherosclerosis, excluding cerebral and coronary sclerosis

516

1908

2.19

56.85

1.5

52461.60

58076.99

e6/l

0.19

306

1167

Preparatory care for dialysis

161

6.37

56.51

1.6

1.4

36927.35

114874.67

e6/l

0.93

Codeine

669

1817

2.03

56.37

1.5

1.4

55303.68

52328.97

e6/l

0.11

392

1058

Pleural plaque

131

286

4.71

55.87

1.4

1.2

146495.70

27736.03

e6/l

1.74

151

COPD, hospital admission 2, with asthma infections

410

1489

2.39

55.83

1.4

1.5

81015.25

62464.66

e6/l

0.33

254

887

Non-allergic asthma (mode)

107

194

5.51

55.37

1.6

1.2

95858.32

25926.49

e6/l

1.01

Hyperkalaemia

111

213

5.45

55.33

1.5

1.4

43182.74

67294.94

e6/l

0.30

125

Undetermined asthma, excluding more controls

9.78

55.33

1.5

1.3

44243.32

58417.19

e6/l

0.16

Primary_lymphoid and hematopoietic malignant neoplasms

292

1083

2.75

54.92

1.6

1.5

84437.02

56938.71

e6/l

0.42

180

643

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

153

382

4.09

54.76

1.5

47991.66

63162.09

e6/l

0.21

222

Calcific aortic valvular stenosis

396

1662

2.37

54.64

1.6

1.5

50116.13

63781.72

e6/l

0.50

240

985

Calcific aortic valvular stenosis, operated

396

1662

2.37

54.64

1.6

1.5

50116.13

63781.72

e6/l

0.50

240

985

COPD, hospital admissions 3, with asthma pneumonia sepsis

369

1288

2.48

54.50

1.5

70521.56

65764.89

e6/l

0.07

226

763

Pain in throat and chest

579

1697

2.10

54.32

1.5

1.4

73087.83

49450.29

e6/l

0.73

354

968

Iron deficiency anaemia

415

1804

2.30

54.09

1.5

63963.16

56650.79

e6/l

0.22

254

1051

Calcific aortic valvular stenosis, diagnosis (helper)

394

1660

2.36

53.89

1.6

1.5

50323.73

63900.83

e6/l

0.49

239

983

Operations 2 for CAVS

394

1660

2.36

53.89

1.6

1.5

50323.73

63900.83

e6/l

0.49

239

983

Polyarthropathies

620

2059

2.02

53.77

1.5

1.4

49635.89

55061.70

e6/l

0.22

371

1230

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

11.03

53.60

1.2

1.5

24935.06

168302.68

e6/l

0.56

Calcific aortic valvular stenosis, including rheumatic fever

394

1665

2.36

53.41

1.6

1.5

50323.73

63716.71

e6/l

0.48

239

986

Diabetic nephropathy

223

717

3.15

53.22

1.6

1.5

32449.72

54118.04

e6/l

1.12

141

408

Secondary hypertension

139

6.40

52.65

1.4

1.2

51122.02

78150.57

e6/l

0.27

Dialysis

7.81

52.52

1.5

1.4

9352.92

64940.82

e6/l

1.25

Cardiovascular diseases

263

467

3.08

51.99

1.5

1.3

37542.49

56289.19

e6/l

0.66

148

284

Chronic periodontitis

195

602

3.31

50.95

1.6

1.4

61276.85

50800.59

e6/l

0.19

124

362

L04AD Calcineurin inhibitors

121

269

4.60

50.41

1.7

1.5

43820.04

80418.89

e6/l

0.52

160

Streptococcal septicaemia

125

286

4.50

50.36

1.6

1.4

89361.27

64352.14

e6/l

0.31

169

Provisional assignment of new diseases of uncertain etiology

359

1532

2.36

49.99

1.6

1.5

74852.59

55808.44

e6/l

0.29

183

926

Codes for special purposes

359

1534

2.36

49.84

1.6

1.5

74852.59

55748.89

e6/l

0.29

183

927

ILD medications: immunosuppressive drugs

449

2013

2.15

49.71

1.5

1.4

41932.82

54226.43

e6/l

0.55

260

1199

Covid-19 confirmed case

273

1031

2.68

49.44

1.5

51943.64

63618.88

e6/l

0.22

128

619

Other respiratory disorders and diseases

264

988

2.72

48.90

1.5

100576.34

59250.17

e6/l

0.81

178

586

Other diseases of the respiratory system

264

988

2.72

48.90

1.5

100576.34

59250.17

e6/l

0.81

178

586

Other disorders of skin and subcutaneous tissue

594

2833

1.94

48.57

1.5

60853.49

54317.21

e6/l

0.20

360

1686

Hypertension, essential

541

1502

2.07

48.14

1.5

1.4

45006.66

56751.35

e6/l

0.45

305

929

Nutritional anaemias

467

2189

2.10

48.08

1.5

57569.08

56512.90

e6/l

0.03

288

1282

Allergic asthma (mode), excluding more controls

7.34

47.90

1.3

1.2

41715.36

46748.48

e6/l

0.06

In situ neoplasms

263

941

2.69

47.72

1.5

55563.21

57008.49

e6/l

0.03

132

562

Parasetamol

570

1434

2.04

47.52

1.5

1.4

65205.59

46998.92

e6/l

0.59

339

831

Hernia of abdominal wall, postoperative

142

376

3.82

46.73

1.5

33844.33

46022.07

e6/l

0.32

210

Endocarditis

8.87

45.85

1.5

1.3

27794.62

66233.68

e6/l

0.54

Lung transplant status

33.95

45.84

1.6

1.5

145048.10

33838.00

e6/l

—

Lung transplantation

33.94

45.84

1.6

1.5

145048.10

33838.00

e6/l

—

Abscess of lung

11.89

45.70

1.4

1.3

26536.76

44258.08

e6/l

0.58

Chronic periapical parodontitis

217

761

2.89

45.40

1.5

1.4

100267.99

51127.35

e6/l

0.78

137

447

Other and unspecified iron deficiency

313

1321

2.40

44.86

1.6

1.5

64673.28

56075.47

e6/l

0.22

191

781

Type 2 diabetes, wide definition

674

2398

1.84

44.61

1.5

1.4

44711.52

61228.62

e6/l

0.89

386

1457

Insulin medication

533

2346

1.96

44.57

1.6

1.4

37000.97

62648.41

e6/l

1.89

324

1424

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

516

2646

1.96

44.33

1.5

86575.66

49575.22

e6/l

1.03

294

1600

Chronic lower respiratory diseases

878

2779

1.72

43.99

1.5

66086.19

53112.97

e6/l

0.46

525

1659

Amputation

153

446

3.53

43.96

1.6

1.4

94536.10

48210.49

e6/l

0.54

278

Oedema, not elsewhere classified

285

1163

2.46

43.47

1.6

1.4

54860.69

52623.77

e6/l

0.04

176

671

Disorders of lipoprotein metabolism and other lipidaemias

678

2350

1.83

43.14

1.5

1.4

59755.91

53786.53

e6/l

0.18

389

1423

Secondary uncertain malignant neoplasm

176

567

3.18

43.00

1.6

1.5

38662.72

71353.16

e6/l

1.08

116

341

Peripheral arterial reconstruction

240

933

2.63

41.38

1.5

1.4

59635.82

62635.86

e6/l

0.05

141

565

Benign neoplasms

415

1095

2.15

41.08

1.5

1.4

69079.53

57140.24

e6/l

0.25

250

669

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

180

473

3.11

41.01

1.4

1.5

32568.10

44273.22

e6/l

0.30

103

268

Hypo-osmolality and hyponatraemia

195

685

2.89

40.54

1.6

1.5

46830.04

59489.45

e6/l

0.30

137

412

Later onset COPD

374

1372

2.18

40.42

1.5

49349.15

69612.47

e6/l

0.89

238

812

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

394

1264

2.14

40.34

1.4

1.5

74992.32

57945.05

e6/l

0.45

229

760

Type 1 diabetes

219

821

2.69

40.20

1.6

1.4

43141.29

62310.76

e6/l

0.47

133

500

Hypothyroidism (congenital or acquired)

5.83

39.79

1.6

1.4

13235.52

58334.63

e6/l

0.94

Autoimmune diseases excluding thyroid diseases

790

2570

1.71

39.68

1.5

1.4

41934.85

60653.65

e6/l

1.50

475

1546

Hypertensive diseases

520

1516

1.95

39.63

1.5

1.4

47748.27

56531.43

e6/l

0.30

301

939

Chronic periodontitis, complicated

124

338

3.76

39.45

1.6

1.4

45924.21

75519.74

e6/l

0.41

202

Hypertension

519

1516

1.95

39.31

1.5

1.4

47901.77

56531.43

e6/l

0.29

300

939

Gout

342

1443

2.19

38.92

1.6

1.4

55039.16

62586.12

e6/l

0.20

209

881

Autoimmune diseases excluding thyroid diseases, strict definition

767

2501

1.72

38.80

1.5

1.4

42168.89

61688.68

e6/l

1.54

464

1503

Hypothyroidism, drug reimbursement

7.55

38.70

1.7

1.3

114619.66

27109.89

e6/l

0.55

Diseases of oesophagus, stomach and duodenum

785

2831

1.69

38.45

1.5

1.4

62421.15

50177.71

e6/l

0.60

463

1705

Anaemia in chronic diseases classified elsewhere

7.39

38.14

1.5

1.4

38872.40

75956.00

e6/l

0.51

Diseases of pulp and periapical tissues

298

1324

2.27

37.99

1.5

1.4

82549.18

52716.24

e6/l

0.59

186

780

Hard cardiovascular diseases

633

2292

1.78

37.63

1.5

50895.46

57556.73

e6/l

0.21

396

1346

Gout, FINNGEN

342

1617

2.15

37.53

1.6

1.4

55039.16

69287.35

e6/l

0.42

209

979

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

175

608

2.94

37.49

1.8

1.4

37596.38

68587.50

e6/l

0.96

105

361

Other dialysis

6.68

37.47

1.7

1.4

11235.23

86867.19

e6/l

1.08

Hypothyroidism and >3 levothyroxin purchases

5.65

37.40

1.6

1.4

13494.75

58334.63

e6/l

0.94

Hypothyroidism, levothyroxine purchases

5.65

37.40

1.6

1.4

13494.75

58334.63

e6/l

0.94

Asthma, hospital admission 2, infections

458

2361

1.92

37.31

1.4

55890.74

55006.54

e6/l

0.02

273

1408

Asthma-related infections

458

2361

1.92

37.31

1.4

55890.74

55006.54

e6/l

0.02

273

1408

484

2368

1.89

37.07

1.5

61990.06

60937.52

e6/l

0.03

304

1427

Cardiodefibrillation

394

1971

2.02

36.92

1.6

1.5

61903.88

59579.94

e6/l

0.06

237

1187

Alcohol use disorder, Swedish definition

465

2291

1.90

36.14

1.5

54687.64

63383.00

e6/l

0.29

296

1375

Insulin, fast-acting

318

1482

2.16

36.01

1.6

1.4

36481.53

57542.54

e6/l

0.89

191

888

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

358

1171

2.13

35.98

1.4

1.5

70794.26

59225.44

e6/l

0.26

201

705

malignant neoplasm of female genital organs

146

469

3.17

35.83

1.3

1.4

30128.06

60704.07

e6/l

0.82

274

Depression medications

5.15

35.44

1.5

1.4

97129.19

56617.78

e6/l

0.31

Peripheral artery operations in Hilmo

173

616

2.87

35.42

1.5

1.4

96466.76

70104.26

e6/l

0.28

101

376

STROKE

431

1529

1.97

35.36

1.5

1.4

43414.87

57455.66

e6/l

0.57

271

889

Substance abuse, excluding more controls

452

2088

1.91

35.34

1.5

62295.35

58524.30

e6/l

0.10

289

1234

Amputation of toe

112

308

3.75

35.33

1.6

1.4

101270.01

52583.74

e6/l

0.40

185

Serous carcinoma of ovary

6.58

35.29

1.2

1.3

24935.06

154578.22

e6/l

0.83

Insulin, combination of fast acting with intermediate-acting or long-acting

534

2753

1.80

35.08

1.6

1.4

36887.42

62116.64

e6/l

1.99

325

1675

Fall on same level

800

2720

1.65

35.07

1.5

1.4

64632.39

54034.22

e6/l

0.41

479

1632

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

172

4.81

34.98

1.4

15469.24

88027.62

e6/l

1.19

102

Non-follicular lymphoma, hilmo, excluding all cancers

103

270

3.90

34.65

1.5

25807.93

82942.89

e6/l

1.03

159

492

2418

1.83

34.24

1.5

62491.45

60560.03

e6/l

0.05

312

1454

L04AA Selective immunosuppressants

178

654

2.75

34.22

1.7

1.4

49587.24

64618.22

e6/l

0.24

102

382

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

357

1186

2.08

33.92

1.4

1.5

71988.40

58396.69

e6/l

0.31

209

717

Pure hypercholesterolaemia

590

2269

1.76

33.62

1.5

77192.46

53390.89

e6/l

0.76

331

1376

Mental and behavioural disorders due to psychoactive substance use

463

2373

1.85

33.59

1.5

61809.99

60713.96

e6/l

0.03

296

1424

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

200

356

2.83

33.59

1.4

1.3

81369.41

41869.51

e6/l

0.50

116

212

Diseases of the digestive system

419

2209

1.91

33.51

1.5

64790.69

58908.89

e6/l

0.16

269

1309

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

353

1180

2.07

33.33

1.4

1.5

71558.19

58736.15

e6/l

0.29

199

712

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

461

2518

1.84

33.14

1.4

1.5

74834.39

50214.74

e6/l

0.78

266

1508

Malignant neoplasm of ovary

126

5.42

33.12

1.2

1.3

18240.29

136606.99

e6/l

1.08

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

126

389

3.30

33.09

1.4

1.5

73074.99

68125.20

e6/l

0.04

224

Type 1 diabetes, wide definition, subgroup 1

167

604

2.79

33.00

1.6

1.4

49894.06

70046.31

e6/l

0.34

366

Substance abuse

452

2347

1.85

32.85

1.5

62295.35

60262.56

e6/l

0.05

289

1410

Disorders resulting from impaired renal tubular function

113

5.72

32.79

1.7

1.3

85410.71

59875.00

e6/l

0.16

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

112

324

3.53

32.61

1.4

1.5

79745.27

53001.36

e6/l

0.26

188

Insulin, fast-acting or short human

320

1556

2.07

32.48

1.6

1.5

36292.57

54482.68

e6/l

0.74

192

931

Diseases of liver

285

1328

2.17

32.43

1.7

1.4

40033.83

54803.56

e6/l

0.59

176

785

Coronary atherosclerosis

576

2138

1.75

32.15

1.5

57341.46

60566.14

e6/l

0.08

352

1262

Enterocolitis due to Clostridium difficile

134

438

3.12

32.05

1.5

1.4

36796.62

65129.18

e6/l

0.69

267

Benign neoplasm: Colon, unspecified

195

771

2.55

32.04

1.5

55673.92

61212.52

e6/l

0.10

115

456

Insulin, intermediate and long-acting

471

2569

1.81

31.92

1.6

1.4

39544.46

63495.64

e6/l

1.59

285

1559

Kidney transplant status

123

5.35

31.83

1.7

1.5

7041.24

90406.03

e6/l

1.75

Other bacterial intestinal infections

180

694

2.63

31.57

1.5

31691.37

69046.53

e6/l

1.61

114

423

COPD-related respiratory insufficiency

157

570

2.82

31.14

1.4

82499.33

81692.03

e6/l

0.01

332

Undetermined asthma

127

5.08

30.49

1.5

1.3

44243.32

31431.83

e6/l

0.20

ILD, hospital admission 2, with pulmonary infections

104

300

3.54

30.45

1.6

1.3

106408.37

100518.49

e6/l

0.04

173

Cerebrovascular diseases

631

2725

1.67

30.45

1.5

64398.78

57555.02

e6/l

0.24

391

1628

Major coronary heart disease event

612

2435

1.69

30.33

1.5

50482.70

59719.55

e6/l

0.31

380

1446

Type 1 diabetes, wide definition

176

684

2.59

30.22

1.6

1.5

47581.12

65003.21

e6/l

0.31

102

415

Myocardial infarction

471

1885

1.81

30.06

1.5

57289.52

61689.17

e6/l

0.09

295

1128

ILD, hospital admissions 3, with pneumonia sepsis

270

3.68

30.01

1.6

1.3

104212.10

102068.40

e6/l

0.01

156

Diabetes mellitus

696

2552

1.63

29.95

1.5

1.4

45757.23

59258.44

e6/l

0.70

392

1553

Major coronary heart disease event excluding revascularizations

578

2357

1.70

29.89

1.5

50591.27

60570.79

e6/l

0.30

360

1398

Diabetes, varying definitions

695

2555

1.63

29.76

1.5

1.4

46225.72

59270.86

e6/l

0.67

394

1553

Gout, idiopatic and unspecified

275

1315

2.12

29.47

1.7

1.4

58349.71

61421.88

e6/l

0.06

163

793

Other diseases of the digestive system

324

1645

1.99

29.35

1.6

1.5

76463.58

60753.76

e6/l

0.41

209

961

Care involving use of rehabilitation procedures

408

2114

1.84

29.24

1.4

46699.99

56720.28

e6/l

0.37

250

1257

Gout, strict definition

213

922

2.35

29.24

1.7

1.4

40874.92

60791.78

e6/l

0.61

127

553

GI-bleeding

327

1670

1.98

29.12

1.6

1.5

74631.42

60414.90

e6/l

0.37

214

978

Enlarged lymph nodes

138

485

2.88

28.94

1.6

1.4

51446.82

61850.36

e6/l

0.20

276

Secondary and unspecified malignant neoplasm of lymph nodes

106

322

3.37

28.71

1.7

1.4

31199.92

94194.54

e6/l

1.38

191

Heart failure and hypertrophic cardiomyopathy

7.13

28.43

1.9

1.3

9861.77

43986.15

e6/l

1.04

Bacterial intestinal infections, IBD co-morbidities

177

715

2.51

28.23

1.5

1.4

30846.75

57182.81

e6/l

1.07

112

434

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

145

4.68

28.11

1.3

1.5

88276.75

65857.09

e6/l

0.15

Disorders of lens

543

2013

1.71

28.10

1.5

75629.92

53127.54

e6/l

0.59

293

1251

Intestinal infectious diseases

643

3109

1.62

27.90

1.5

1.4

35094.28

58668.52

e6/l

2.39

401

1836

Antihypertensive medication - note that there are other indications

253

617

2.25

27.85

1.5

1.4

69375.18

48878.45

e6/l

0.31

141

368

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

242

3.71

27.73

1.6

1.5

38879.08

67658.09

e6/l

0.42

137

Other diseases of blood and blood-forming organs, wide

195

834

2.37

27.43

1.5

95412.36

56409.82

e6/l

0.46

127

484

Gout, unspecified

229

1054

2.21

27.14

1.7

1.5

64033.60

63702.65

e6/l

0.01

144

631

Chronic lymphocytic leukaemia, helper endpoint

6.20

27.06

1.7

1.6

91998.03

112832.13

e6/l

0.08

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

6.20

27.06

1.7

1.6

91998.03

112832.13

e6/l

0.08

Lymphoid leukaemia

154

4.46

26.99

1.7

1.5

71351.96

72760.27

e6/l

0.01

Codeine or tramadol medication

804

2894

1.54

26.98

1.5

1.4

53152.52

54854.42

e6/l

0.07

473

1742

Cardiomyopathy, Hypertrophic obstructive

10.10

26.95

1.6

1.2

12104.89

120841.79

e6/l

0.82

Fibrosis and cirrhosis of liver

276

3.49

26.90

1.8

1.4

18050.43

92831.04

e6/l

1.81

169

Amiodarone users

132

474

2.85

26.83

1.5

1.4

22029.97

69096.66

e6/l

2.00

283

Disorders of choroid and retina

641

2925

1.60

26.63

1.5

68740.49

54794.84

e6/l

0.36

373

1768

Iron deficiency anaemia secondary to blood loss (chronic)

161

642

2.54

26.46

1.4

60117.13

64468.35

e6/l

0.07

101

378

Benign neoplasm of colon, rectum, anus and anal canal

523

2843

1.67

26.45

1.5

63785.19

57400.06

e6/l

0.16

306

1729

COPD, hospital admissions 1, only main diagnosis

365

1688

1.86

26.35

1.4

1.5

76984.54

60687.96

e6/l

0.27

236

1009

Ischemic heart diseases

592

2269

1.64

26.29

1.5

54968.20

59053.11

e6/l

0.11

368

1339

Cirrhosis of liver, NAS

184

4.10

26.15

1.9

1.4

21004.00

100224.33

e6/l

1.35

112

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

127

319

2.98

26.12

1.6

1.4

126515.90

28641.63

e6/l

1.59

180

Nonischemic cardiomyopathy

184

4.07

26.09

1.5

1.4

26044.77

95099.10

e6/l

1.12

112

Diarrhoea and gastroenteritis of presumed infectious origin

470

2508

1.71

26.07

1.5

1.4

37412.63

58369.46

e6/l

1.50

292

1471

Pain, not elsewhere classified

183

779

2.37

25.96

1.5

1.4

33564.20

52077.58

e6/l

0.72

112

443

Allergic asthma (mode)

167

4.13

25.90

1.3

41715.36

28790.85

e6/l

0.20

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

658

2535

1.59

25.68

1.5

1.4

39007.69

59507.60

e6/l

1.53

379

1543

Type 2 diabetes

671

2522

1.59

25.66

1.5

1.4

47319.79

59676.88

e6/l

0.60

382

1536

Alcoholic liver disease

116

400

2.96

25.38

1.7

1.4

47305.71

87287.12

e6/l

0.81

243

Other CVD

207

943

2.23

25.17

1.6

1.4

51333.76

68020.08

e6/l

0.25

135

565

Ischaemic heart disease, wide definition

583

2251

1.63

25.12

1.5

54073.47

59256.45

e6/l

0.15

359

1330

Injuries to the head

736

3128

1.54

25.11

1.5

1.4

59341.46

54805.44

e6/l

0.13

455

1866

Invasive ventilation

259

3.48

25.10

1.5

1.4

43006.98

100179.96

e6/l

0.79

157

Mental and behavioural disorders due to alcohol

392

2164

1.77

24.96

1.5

68567.34

56962.04

e6/l

0.33

248

1308

Benign neoplasm: Sigmoid colon

140

537

2.64

24.91

1.6

1.5

66179.13

60988.37

e6/l

0.06

314

Infections of the skin and subcutaneous tissue

381

2139

1.78

24.82

1.6

1.5

47467.14

54937.44

e6/l

0.26

238

1278

Hodgkin lymphoma

7.42

24.70

1.9

1.3

18943.15

49712.35

e6/l

0.38

Other acute lower respiratory infections

404

2212

1.75

24.64

1.5

73949.00

52228.88

e6/l

0.57

262

1325

Examination and observation for other reasons

437

1524

1.75

24.50

1.5

1.4

50377.98

49953.08

e6/l

0.01

311

839

Diabetes medication

687

2691

1.56

24.46

1.5

1.4

49115.28

58163.08

e6/l

0.41

392

1629

Mental and behavioural disorders due to alcohol, excluding acute intoxication

351

1943

1.82

24.32

1.5

61592.97

57403.63

e6/l

0.10

221

1172

Glucagon-like peptide-1 (GLP-1) analogues

476

2346

1.68

24.28

1.6

1.4

41585.75

61859.15

e6/l

1.39

288

1422

Acute peritonitis

228

3.59

24.00

1.5

1.4

14887.59

84230.04

e6/l

1.53

139

Coronary artery bypass grafting

316

1278

1.90

24.00

1.5

96625.52

71589.25

e6/l

0.47

198

770

Vocal cord dysfunction

286

3.18

23.93

1.5

1.4

113073.85

39139.63

e6/l

0.65

167

Use of hypnotics and sedatives

738

2803

1.53

23.91

1.5

73974.89

52275.02

e6/l

0.73

451

1680

Endocrine, nutritional and metabolic diseases

481

1436

1.71

23.86

1.5

1.4

73806.86

49712.58

e6/l

0.66

283

859

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

123

432

2.76

23.78

1.4

41200.58

45629.98

e6/l

0.07

249

Direct fill therapy

112

392

2.89

23.77

1.7

1.4

47218.40

85883.68

e6/l

0.72

232

Other disorders of kidney and ureter

132

505

2.66

23.71

1.6

1.4

59282.58

75269.54

e6/l

0.18

302

Diabetic retinopathy, excluding more controls

208

519

2.28

23.69

1.5

26976.79

43871.90

e6/l

0.95

121

287

Diabetes, insulin treatment (Kela reimbursement)

699

2798

1.53

23.32

1.5

1.4

38301.95

61497.78

e6/l

1.99

399

1692

Symptoms and signs involving the urinary system

583

2861

1.58

23.26

1.5

58931.15

55707.88

e6/l

0.10

346

1717

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

9.44

23.13

1.6

1.2

10690.64

206005.72

e6/l

0.49

Convulsions, not elsewhere classified

162

681

2.37

22.99

1.5

1.4

68418.42

55275.43

e6/l

0.22

100

394

Other retinal disorders

521

2601

1.62

22.93

1.5

64753.07

55806.44

e6/l

0.18

308

1570

777

2739

1.50

22.91

1.5

1.4

72667.55

50512.53

e6/l

0.80

489

1606

Malignant neoplasm of breast

292

1105

1.92

22.69

1.4

36295.35

42839.65

e6/l

0.21

161

629

Stroke, including SAH

539

2504

1.60

22.46

1.5

59151.02

57889.26

e6/l

0.04

334

1491

Benign neoplasm: Colon

447

2654

1.66

22.45

1.5

63280.14

57394.89

e6/l

0.13

267

1590

Benign neoplasm: Transverse colon

283

3.20

22.41

1.4

1.6

93397.39

60223.36

e6/l

0.22

165

Fentanyl

107

378

2.87

22.38

1.5

46857.37

54526.44

e6/l

0.14

228

Malignant neoplasm of breast, HER2-negative

286

1108

1.91

21.99

1.4

36482.16

42828.86

e6/l

0.20

158

631

Sub-endpoint used in defining T1D endpoints

236

1168

2.00

21.97

1.5

41270.15

65209.75

e6/l

0.73

143

687

Malignant neoplasm of other and unspecified female genital organs

7.87

21.91

1.6

1.2

11879.72

212006.05

e6/l

0.65

Pain in limb

532

2422

1.59

21.76

1.5

1.4

56096.14

51856.98

e6/l

0.11

310

1442

Viral hepatitis, IBD co-morbidity

5.25

21.74

1.5

31551.59

27445.35

e6/l

0.09

Fungal Sepsis

113

4.65

21.61

1.7

1.4

24155.18

115561.81

e6/l

0.92

Senile cataract

504

1934

1.63

21.55

1.4

1.5

73861.42

53920.15

e6/l

0.46

264

1198

Asthma and allergy, excluding more controls

8.41

21.54

1.6

1.2

14235.67

15615.00

e6/l

0.05

Myocardial infarction, without ST-elevation

396

2174

1.70

21.26

1.4

1.5

44190.86

62364.75

e6/l

0.78

250

1305

All influenza (not pneumonia)

335

2.92

21.11

1.6

1.4

26362.45

88329.79

e6/l

1.58

200

Hypertensive Renal Disease

145

4.13

21.08

1.6

1.4

32569.00

85918.59

e6/l

0.60

Nephrotic syndrome

5.16

21.04

1.6

1.4

199715.88

27717.96

e6/l

0.45

Disorders of gallbladder, biliary tract and pancreas

695

3002

1.50

21.00

1.5

59975.10

55892.13

e6/l

0.12

423

1792

Benign neoplasm: Ascending colon

103

371

2.81

20.82

1.8

1.5

35744.97

63674.28

e6/l

0.51

215

Bronchitis

708

3134

1.49

20.73

1.5

1.4

69841.28

52410.10

e6/l

0.68

456

1846

Cough

252

1269

1.92

20.66

1.5

1.4

59634.12

45623.54

e6/l

0.26

166

707

Glomerulonephritis

346

2.88

20.59

1.5

1.4

93708.41

92975.31

e6/l

0.00

215

Agranulocytosis

102

368

2.81

20.58

1.5

1.4

46184.38

85797.64

e6/l

0.70

208

Early onset COPD

193

927

2.10

20.57

1.4

1.5

95454.23

60275.27

e6/l

0.33

120

542

Syncope and collapse

326

1641

1.77

20.46

1.6

1.4

70794.69

51718.54

e6/l

0.40

200

970

Other disorders of glucose regulation and pancreatic internal secretion

259

3.18

20.25

1.5

1.4

82319.34

77213.81

e6/l

0.04

159

Osteopathies and chondropathies

380

2154

1.68

20.08

1.5

64829.72

47818.64

e6/l

0.40

232

1247

Intestinal stricture

266

1440

1.86

20.06

1.4

1.5

53082.30

59353.03

e6/l

0.08

158

854

Hypertrophic cardiomyopathy

146

4.02

20.05

1.8

1.4

14937.76

82816.15

e6/l

1.54

Myocardial infarction, strict

411

1812

1.67

20.00

1.4

1.5

58443.88

62759.46

e6/l

0.08

253

1084

Unspecified privation

357

2.81

20.00

1.6

1.4

47179.25

72828.74

e6/l

0.28

223

Hypokalaemia

102

374

2.76

19.96

1.4

85905.31

60638.90

e6/l

0.27

219

Left ventricular outflow tract obstruction (LVOTO), broad definition

282

3.06

19.95

1.5

61599.36

78998.12

e6/l

0.26

167

Fracture of femur

256

1247

1.89

19.93

1.4

36567.76

60091.24

e6/l

1.18

156

738

Diffuse large B-cell lymphoma, helper endpoint

121

4.33

19.83

1.5

34054.35

89043.15

e6/l

0.48

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

121

4.33

19.83

1.5

34054.35

89043.15

e6/l

0.48

Persons encountering health services for specific procedures, not carried out

160

3.80

19.82

1.6

1.4

26335.66

119623.61

e6/l

1.04

Benign neoplasm: Rectum, anus and anal canal

140

600

2.36

19.75

1.5

52302.65

61714.51

e6/l

0.17

355

Benign neoplasm: Rectum

127

522

2.46

19.67

1.5

55784.71

61731.76

e6/l

0.09

306

Other disorders of teeth and supporting structures

171

800

2.16

19.53

1.6

1.4

121858.33

49628.34

e6/l

0.66

104

472

Other soft tissue disorders, not elsewhere classified

605

2468

1.52

19.51

1.5

1.4

64878.06

51369.20

e6/l

0.41

352

1470

Symptoms and signs concerning food and fluid intake

334

2.85

19.48

1.5

1.4

81471.54

70646.35

e6/l

0.10

195

Conotruncal defects

15.96

19.43

1.6

1.5

100279.36

21535.00

e6/l

—

Substance use, excluding alcohol

125

513

2.46

19.39

1.4

26872.98

61666.16

e6/l

1.29

301

Gastroduodenal ulcer

259

1403

1.86

19.36

1.4

1.5

47002.10

58185.71

e6/l

0.37

160

834

Amputation of foot

108

4.55

19.17

1.5

1.4

45942.62

79599.86

e6/l

0.37

Other abnormalities of plasma proteins

6.67

19.04

1.9

1.2

23038.71

29158.61

e6/l

0.18

Diseases of the skin and subcutaneous tissue

684

2317

1.48

18.96

1.5

1.4

49589.61

51120.61

e6/l

0.05

413

1398

Chronic viral hepatitis

5.28

18.93

1.6

1.4

32908.46

20139.42

e6/l

0.36

Stroke, excluding SAH

509

2442

1.56

18.92

1.5

57900.62

59194.69

e6/l

0.04

317

1451

Hypoglycaemia, other or unspecified

204

3.39

18.89

1.5

1.4

77697.05

92023.09

e6/l

0.09

128

Polyneuropathies and other disorders of the peripheral nervous system

198

997

2.01

18.63

1.6

1.5

71074.72

64450.41

e6/l

0.06

114

592

Chronic pancreatitis

117

476

2.49

18.61

1.6

1.4

25200.94

72170.37

e6/l

1.66

273

Unspecified acute lower respiratory infection

122

506

2.44

18.56

1.4

1.5

64214.44

64783.05

e6/l

0.01

300

Insulin, fast-acting (human)

103

395

2.63

18.45

1.5

1.4

56496.57

86254.64

e6/l

0.34

241

Oesophageal varices

137

3.98

18.42

1.8

1.4

67439.09

101772.01

e6/l

0.25

Non-small cell lung cancer, squamous, helper endpoint

270

3.05

18.40

1.4

15469.24

61894.58

e6/l

2.13

163

Non-small cell lung cancer, squamous

270

3.05

18.40

1.4

15469.24

61894.58

e6/l

2.13

163

Alcohol use disorder, ICD-based

310

1803

1.73

18.35

1.6

1.5

47112.91

58765.64

e6/l

0.39

193

1094

L02BA Anti-estrogens

108

426

2.56

18.27

1.4

24559.69

61910.89

e6/l

0.96

239

Autoimmune diseases

730

2574

1.45

18.21

1.5

1.4

44487.99

60624.05

e6/l

0.84

444

1548

Secondary right heart disease

176

3.57

18.12

1.4

15604.82

101611.10

e6/l

1.46

109

Hyperlipidaemia, other/unspecified

325

1817

1.71

18.07

1.5

43993.35

55206.28

e6/l

0.49

194

1098

Cardiac arrest

136

3.73

17.90

1.5

1.3

36506.16

75804.99

e6/l

0.60

Implicit fungal Sepsis

101

4.48

17.89

1.7

1.4

26416.94

108542.30

e6/l

0.72

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

109

421

2.53

17.88

1.7

1.4

67724.15

83495.01

e6/l

0.18

242

Asthma (diagnoses ohter than nonallergic)

560

3210

1.50

17.85

1.5

55760.63

55925.35

e6/l

0.00

332

1928

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

127

4.03

17.79

1.3

1.5

34208.56

80504.34

e6/l

0.45

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

659

2953

1.46

17.59

1.6

1.4

62715.17

55955.43

e6/l

0.24

391

1782

Aortic valve malfunction, age under 60 years

260

3.00

17.58

1.4

66611.53

81915.88

e6/l

0.20

153

Injuries to the thorax

343

2074

1.66

17.58

1.5

98100.72

49578.22

e6/l

1.31

212

1244

Sequelae of external causes of morbidity and mortality

196

1005

1.97

17.51

1.5

1.4

79170.97

61054.27

e6/l

0.31

114

595

Hodgkin lymphoma, hilmo

5.21

17.50

1.9

1.3

18943.15

49357.83

e6/l

0.73

Coagulation defects, purpura and other haemorrhagic conditions

149

691

2.18

17.47

1.4

100391.03

67192.50

e6/l

0.27

419

Abnormal findings on examination of blood, without diagnosis

389

2271

1.61

17.44

1.6

1.5

68921.54

60938.64

e6/l

0.15

226

1399

Cellulitis

165

797

2.09

17.40

1.6

1.5

51442.09

66746.04

e6/l

0.33

106

461

Used for control exclusion in common control thyroid runs

691

2415

1.45

17.38

1.6

1.4

45010.55

62352.14

e6/l

0.86

417

1456

Abnormalities of heart beat

213

1114

1.91

17.38

1.5

1.4

42013.42

46595.34

e6/l

0.15

135

618

Osteomyelitis

231

3.14

17.35

1.7

1.4

43256.05

62995.06

e6/l

0.34

133

Nausea and vomiting

193

971

1.97

17.27

1.5

60521.53

61745.76

e6/l

0.02

114

568

Coronary revascularization (ANGIO or CABG)

404

1760

1.61

17.21

1.5

79106.64

64148.41

e6/l

0.32

250

1049

Chronic ulcer of skin, not elsewhere classified

270

2.95

17.11

1.6

1.4

25223.76

66824.32

e6/l

1.02

160

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

109

4.23

17.06

1.5

1.6

33871.71

90376.95

e6/l

0.44

Asthma/COPD (KELA code 203)

581

2774

1.48

17.05

1.5

67399.31

53196.01

e6/l

0.49

355

1656

Deposits [accretions] on teeth

180

3.38

17.04

1.5

111997.53

74266.50

e6/l

0.16

117

Non-follicular lymphoma

103

415

2.53

16.81

1.5

1.4

25807.93

82286.98

e6/l

1.69

241

Other diseases of intestines

652

2617

1.45

16.75

1.5

1.4

68028.52

54022.41

e6/l

0.41

390

1569

Other cataract

343

1611

1.66

16.72

1.5

69497.19

52427.83

e6/l

0.50

221

998

Symptoms and signs involving the digestive system and abdomen

683

2372

1.45

16.70

1.5

45216.56

61288.79

e6/l

0.89

420

1424

Ischaemic Stroke, excluding all haemorrhages

480

2383

1.53

16.66

1.4

1.5

58893.49

58847.88

e6/l

0.00

295

1424

Other viral hepatitis

4.34

16.65

1.7

1.4

32688.58

23538.33

e6/l

0.26

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

143

3.72

16.56

1.7

1.5

13291.03

78396.52

e6/l

0.79

Other pulmonary heart/vessel disease

197

3.28

16.51

1.4

15180.20

95597.16

e6/l

1.51

119

Other diseases of intestine

116

498

2.36

16.44

1.6

1.5

26772.49

46576.13

e6/l

0.79

289

Lymphoid leukaemia

218

3.14

16.41

1.7

1.4

71351.96

75173.06

e6/l

0.03

133

Other and unspecified polyneuropathies, also in other diseases

175

884

2.00

16.40

1.6

1.4

78502.73

71493.85

e6/l

0.05

101

515

Pneumonia derived septicemia

104

4.24

16.36

1.3

1.4

122442.58

127821.48

e6/l

0.02

Acute bronchitis

305

1786

1.68

16.35

1.5

83668.54

52349.88

e6/l

0.67

202

1055

Idiopathic gout

104

427

2.48

16.34

1.7

1.4

31939.69

69055.34

e6/l

0.99

267

Artificial opening status

183

3.35

16.33

1.6

1.3

15361.86

88641.21

e6/l

1.21

102

Falls/tendency to fall

690

2410

1.44

16.31

1.5

1.4

78372.44

50027.16

e6/l

1.12

420

1453

Volume depletion

374

2.58

16.26

1.5

1.4

28851.36

63895.08

e6/l

0.84

232

Other (not insulin) diabetes medications

631

2632

1.45

16.20

1.5

1.4

45868.67

58967.17

e6/l

0.72

360

1596

Carcinoma in situ of skin of other and unspecified parts of face

262

2.91

16.19

1.7

1.5

13059.00

54488.02

e6/l

0.97

153

Emergency coronary revascularization (for ACS)

498

2381

1.51

16.15

1.5

75970.39

58384.86

e6/l

0.51

311

1432

Hypotension

164

816

2.03

16.06

1.5

1.4

29071.80

74390.56

e6/l

2.74

104

494

Medical observation and evaluation for suspected diseases and conditions

471

1564

1.55

16.01

1.5

1.4

60390.63

49684.56

e6/l

0.37

329

862

Fracture of rib(s), sternum and thoracic spine

237

1331

1.79

15.97

1.5

117360.03

49607.79

e6/l

1.33

145

801

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

106

4.16

15.96

1.4

1.5

53947.54

97414.67

e6/l

0.26

Paralytic ileus and intestinal obstruction

219

1201

1.84

15.95

1.4

1.5

27255.73

51129.94

e6/l

1.70

130

706

Colorectal cancer, excluding all cancers (controls excluding all cancers)

187

941

1.94

15.94

1.4

1.5

108392.73

57427.20

e6/l

0.56

116

564

Other disorders of skin and subcutaneous tissue, not elsewhere classified

122

543

2.27

15.89

1.5

36627.46

55915.87

e6/l

0.65

326

Pneumococcal septicemia

4.29

15.85

1.3

131633.63

107180.86

e6/l

0.11

Malignant melanoma, excluding all cancers (controls excluding all cancers)

118

522

2.28

15.58

1.6

1.5

62622.89

58747.11

e6/l

0.06

306

Type 2 diabetes, strict (exclude DM1)

607

2508

1.45

15.56

1.5

1.4

44177.94

60214.50

e6/l

0.92

341

1525

Gastric ulcer

170

868

1.98

15.47

1.4

1.5

45090.26

64757.37

e6/l

0.53

106

518

Diseases of peritoneum

384

2.51

15.41

1.5

1.4

22071.39

74105.64

e6/l

1.62

233

Type 2 diabetes, definitions combined

602

2488

1.45

15.38

1.5

1.4

41736.91

60219.56

e6/l

1.17

338

1514

Other or unspecified ileus, impaction or obstruction

167

851

1.98

15.26

1.4

1.5

29913.97

48685.56

e6/l

0.85

100

500

Diabetic retinopathy

277

1019

1.73

15.18

1.5

32411.65

50124.43

e6/l

1.06

159

602

Retention of urine

315

1629

1.65

15.18

1.6

1.5

53613.31

64296.76

e6/l

0.29

189

1007

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

6.73

15.03

1.5

1.4

22559.23

162040.61

e6/l

0.43

Hepatic failure, not elsewhere classified

120

3.85

15.03

1.7

1.3

29508.26

79447.06

e6/l

0.49

Misadventures to patients during surgical and medical care

111

488

2.30

14.92

1.6

1.4

110841.31

63346.73

e6/l

0.38

292

Congenital malformations of cardiac septa

120

3.75

14.90

2.0

1.4

69106.73

26187.47

e6/l

0.86

Hernia

607

2888

1.43

14.85

1.5

55176.30

54177.17

e6/l

0.03

346

1737

Chronic lymphocytic leukaemia

131

3.72

14.80

1.7

1.4

91998.03

102692.29

e6/l

0.05

Diverticular disease of intestine

524

2378

1.47

14.72

1.5

1.4

69724.76

56503.90

e6/l

0.31

312

1430

Unspecified haematuria

353

1918

1.59

14.69

1.5

83356.35

62325.55

e6/l

0.50

210

1183

Constipation

601

3030

1.43

14.57

1.5

78667.87

51686.84

e6/l

0.88

369

1808

Pneumonia due to other infectious organisms, not elsewhere classified

5.03

14.57

1.7

1.3

43774.48

159177.40

e6/l

0.66

254

1481

1.71

14.55

1.4

63141.41

57122.02

e6/l

0.12

147

880

Mental and behavioural disorders due to use of other stimulants, including caffeine

8.38

14.53

1.6

1.3

43759.25

24020.83

e6/l

0.26

Congenital malformations of heart and great arteries

312

2.60

14.51

1.7

1.4

58093.06

81870.80

e6/l

0.32

182

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

4.25

14.49

1.5

238811.20

95475.54

e6/l

0.33

Exposure to unspecified factor

592

3235

1.42

14.49

1.5

1.4

46504.16

56653.62

e6/l

0.52

342

1949

Immunodeficiency with predominantly antibody defects

5.64

14.36

1.6

1.3

47189.29

15462.59

e6/l

0.60

Intracranial trauma

349

1648

1.59

14.36

1.5

1.4

61995.92

42215.03

e6/l

0.40

223

947

Congenital malformations of the circulatory system

360

2.47

14.33

1.8

1.4

56127.00

88270.50

e6/l

0.53

212

Medicines for HER+ breast cancer

199

1070

1.82

14.18

1.4

29199.56

46533.84

e6/l

0.77

117

602

Decubitus ulcer and pressure area

254

2.81

14.18

1.6

1.4

50568.29

51192.31

e6/l

0.01

157

Emphysema

305

2.64

14.16

1.4

37188.04

75522.63

e6/l

0.63

184

Purpura and other haemorrhagic conditions

110

493

2.26

14.16

1.5

1.4

66747.35

74446.92

e6/l

0.07

292

Atrial septal defect

4.89

14.15

2.1

1.3

27184.76

32817.47

e6/l

0.14

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

299

2.64

14.12

1.4

1.5

31238.57

79127.47

e6/l

0.89

171

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

4.54

14.11

1.2

1.5

28529.04

38530.67

e6/l

0.17

340

2.52

14.08

1.6

1.4

54239.26

73943.40

e6/l

0.19

195

Other other unspecified disorders of the circulatory system

121

3.73

14.08

1.8

1.3

122112.19

122617.53

e6/l

0.00

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

4.75

14.06

1.7

1.6

54063.13

128134.35

e6/l

0.41

Symptoms and signs involving cognition, perception, emotional state and behaviour

616

3073

1.41

14.00

1.5

51368.46

56695.01

e6/l

0.21

390

1826

Injuries to the hip and thigh

359

2121

1.56

13.98

1.5

42412.52

57607.53

e6/l

0.77

217

1252

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

343

2.51

13.89

1.6

1.4

148309.21

86793.51

e6/l

0.27

204

Other or ill-defined heart diseases

4.24

13.88

1.4

1.2

71514.50

68499.98

e6/l

0.02

Carcinoma in situ of skin

240

2.84

13.86

1.4

1.5

27182.83

64720.43

e6/l

0.68

143

Tobacco use

122

3.67

13.86

1.5

1.4

27350.85

40329.41

e6/l

0.25

Benign neoplasm of other and ill-defined parts of digestive system

105

466

2.27

13.81

1.6

1.5

46212.55

61329.47

e6/l

0.24

270

Factors influencing health status and contact with health services

213

582

1.84

13.79

1.4

64251.71

53639.95

e6/l

0.18

133

329

Sequelae with surgical and medical care as external cause

154

792

1.96

13.78

1.5

1.4

74208.66

55595.69

e6/l

0.30

466

Bronchiectasis

322

2.56

13.69

1.4

53757.69

91803.39

e6/l

0.46

188

Amyloidosis, other/unspecified

4.97

13.69

1.5

1.4

54984.77

120623.10

e6/l

0.30

Mycoses

184

1005

1.84

13.67

1.5

49956.46

60977.91

e6/l

0.24

110

594

Viral pneumonia (known virus, not influenza)

4.54

13.66

1.5

1.3

23889.52

33388.96

e6/l

0.30

Persons encountering health services in other circumstances, wide

782

2991

1.36

13.62

1.5

1.4

52310.82

56821.35

e6/l

0.16

491

1772

Viral hepatitis

143

3.39

13.55

1.6

1.4

29627.34

72805.57

e6/l

0.48

Viral pneumonia (unknown virus, not influenza)

169

3.18

13.44

1.7

1.4

55358.26

80858.42

e6/l

0.22

100

Gastrointestinal diseases

326

1012

1.62

13.43

1.5

1.4

74627.67

47826.64

e6/l

0.58

197

599

Type 2 diabetes, definitions combined, including avohilmo

591

2478

1.42

13.43

1.5

1.4

41969.61

60939.82

e6/l

1.20

334

1502

Abnormal results of function studies

222

2.87

13.42

1.5

1.4

103134.02

63380.06

e6/l

0.31

127

In situ neoplasms

263

1598

1.66

13.41

1.5

55563.21

56154.10

e6/l

0.01

132

950

L04AX Other immunosuppressants

322

2054

1.57

13.37

1.5

51760.57

50994.80

e6/l

0.02

180

1222

Asthma and opportunity respiratory infection

191

3.06

13.37

1.4

1.3

69474.23

90106.82

e6/l

0.15

114

Benzodiazepine use

630

3236

1.39

13.26

1.4

1.5

54148.77

55698.15

e6/l

0.05

391

1931

Asthma mixed form (mode), excluding more controls

8.55

13.25

1.2

1.3

40696.67

16507.50

e6/l

—

Haemorrhage, not elsewhere classified

141

3.42

13.22

1.4

42836.63

63923.89

e6/l

0.31

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

108

3.78

13.13

1.4

1.6

37281.87

91987.62

e6/l

0.45

Missing teeth due to accident, extraction or parodontitis

427

2.30

13.07

1.6

1.4

186255.30

55590.06

e6/l

0.71

260

Myocarditis

4.54

13.06

1.3

1.2

15056.67

117714.93

e6/l

0.96

Other respiratory diseases principally affecting the interstitium

165

886

1.88

13.02

1.5

107983.71

56491.05

e6/l

0.84

539

Amyloidosis

4.25

12.89

1.4

1.3

48180.13

93976.41

e6/l

0.26

Chronic periodontitis, including avohilmo

572

3026

1.40

12.84

1.5

50279.06

55170.92

e6/l

0.20

340

1816

Other disorders of white blood cells

185

3.03

12.79

1.5

1.4

181894.81

104624.11

e6/l

0.25

107

Immunodeficiencies

110

3.70

12.78

1.6

1.3

45573.17

94055.02

e6/l

0.35

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

327

2.48

12.77

1.8

1.4

109278.79

78883.96

e6/l

0.27

198

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

4.13

12.75

1.4

18173.70

20300.69

e6/l

0.10

Parodontitis or operation codes

574

3029

1.40

12.73

1.5

51193.91

54992.87

e6/l

0.15

340

1818

Biguanides

615

2734

1.39

12.70

1.5

1.4

44146.83

58924.46

e6/l

0.85

347

1653

Certain disorders involving the immune mechanism

130

649

2.02

12.69

1.6

1.4

49628.48

63904.48

e6/l

0.22

379

Malignant neoplasm of skin

499

2631

1.43

12.69

1.4

1.5

79138.32

54833.26

e6/l

0.63

293

1580

Parodontitis

573

3028

1.40

12.67

1.5

51193.91

54992.87

e6/l

0.15

340

1818

Vitreous haemorrhage

377

2.36

12.66

1.5

1.4

39108.74

79814.88

e6/l

0.93

230

Benign neoplasms

616

2476

1.39

12.63

1.5

1.4

68390.76

52680.58

e6/l

0.49

369

1505

Other external causes of accidental injury

535

1877

1.43

12.54

1.5

1.4

81167.09

46256.95

e6/l

1.21

324

1120

Drug-induced neutropenia

231

2.77

12.52

1.5

1.4

22788.16

111079.01

e6/l

1.53

127

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

5.28

12.50

1.4

1.5

11350.75

32074.50

e6/l

0.47

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

130

653

2.01

12.48

1.4

1.5

148246.35

65092.24

e6/l

0.68

381

Malignant neoplasm of urinary organs

103

475

2.20

12.47

1.3

1.4

77965.26

75441.33

e6/l

0.02

291

Second line medication for Crohn's disease

324

2104

1.55

12.47

1.5

51475.76

50848.59

e6/l

0.01

181

1249

Injuries to the abdomen, lower back, lumbar spine and pelvis

267

1648

1.62

12.45

1.5

75237.47

47360.42

e6/l

0.57

176

975

Elevated blood glucose level

266

2.63

12.43

1.6

1.4

73100.66

93454.92

e6/l

0.14

166

Charcot foot

5.51

12.38

1.7

1.2

50676.69

82401.68

e6/l

0.19

Open wound of lower leg

101

463

2.20

12.35

1.6

1.4

111323.88

53975.10

e6/l

0.63

268

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

113

3.62

12.33

1.5

1.6

230222.31

79991.20

e6/l

0.38

Malignant neoplasm of kidney, except renal pelvis

415

2.28

12.21

1.3

1.4

82051.74

81312.59

e6/l

0.01

258

Accidents

532

1877

1.42

12.11

1.5

1.4

79783.64

46256.95

e6/l

1.14

324

1120

Asthma and allergy

4.62

12.11

1.6

1.3

14235.67

9235.38

e6/l

0.22

Systemic lupus erythematosus, unspecified

4.91

11.94

1.5

1.2

56056.40

46651.56

e6/l

0.06

Secondary thrombocytopenia

7.66

11.92

1.4

1.5

30611.82

30471.00

e6/l

—

SLE, strict definition

4.59

11.92

1.4

1.3

52865.38

43977.88

e6/l

0.07

SLE, ICD10

4.59

11.92

1.4

1.3

52865.38

43977.88

e6/l

0.07

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

106

3.64

11.91

1.5

1.6

18580.06

98004.12

e6/l

0.81

Injury of other and unspecified intrathoracic organs

217

2.76

11.69

1.4

250286.68

54581.62

e6/l

1.10

135

Diabetic retinopathy, strict definition

144

674

1.90

11.45

1.6

1.5

34578.50

45824.61

e6/l

0.37

385

Other and unspecified disorders of white blood cells

139

3.23

11.43

1.6

1.4

215821.77

129690.92

e6/l

0.22

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

466

2.15

11.37

1.5

115429.34

71117.00

e6/l

0.25

276

Other embolism and thrombosis

105

506

2.10

11.36

1.6

1.5

47174.15

61145.98

e6/l

0.20

306

Sulfasalazine

168

947

1.78

11.33

1.4

52410.26

56370.55

e6/l

0.09

549

Problems related to lifestyle

255

2.57

11.31

1.5

1.4

31490.55

88129.26

e6/l

1.13

148

SLE (Finngen)

4.27

11.30

1.4

1.3

52865.38

106288.95

e6/l

0.28

Superficial injury of head

146

789

1.86

11.30

1.6

1.4

82419.19

53069.63

e6/l

0.42

465

Left bundle-branch block

171

2.96

11.30

1.3

46153.96

104849.44

e6/l

0.85

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

5.70

11.24

1.2

1.4

37543.33

15044.52

e6/l

—

Other interstitial pulmonary diseases

136

723

1.90

11.16

1.6

1.5

128625.28

60329.23

e6/l

0.95

429

Systemic lupus erythematosus

4.21

11.10

1.4

1.3

52865.37

141487.31

e6/l

0.37

ILD, hospital admissions

134

712

1.90

11.02

1.5

130291.45

61688.34

e6/l

0.93

419

L02BG Aromatase inhibitors

163

919

1.78

11.01

1.4

31857.23

48236.03

e6/l

0.57

528

Chronic gastritis

222

1362

1.64

11.01

1.5

1.4

79038.27

58476.56

e6/l

0.38

132

805

Interstitial lung disease

136

727

1.89

10.98

1.6

1.5

128625.28

60188.13

e6/l

0.95

430

Interstitial lung disease endpoints

136

727

1.89

10.98

1.6

1.5

128625.28

60188.13

e6/l

0.95

430

Restrictive cardiomyopathy

10.29

10.96

1.8

1.4

10605.13

41785.71

e6/l

—

Cutaneous abscess, furuncle and carbuncle

153

848

1.81

10.94

1.6

1.4

58426.56

62211.29

e6/l

0.06

493

Dysphagia

181

1058

1.72

10.80

1.4

1.5

47164.22

60961.51

e6/l

0.32

114

615

Cytomegaloviral disease

5.01

10.79

1.5

1.4

4925.62

47406.52

e6/l

2.05

Diffuse large B-cell lymphoma

182

2.86

10.76

1.5

1.4

34054.35

100524.45

e6/l

0.91

109

Systemic connective tissue disorders

226

1401

1.62

10.74

1.5

36300.86

58958.13

e6/l

0.81

112

826

Malignant neoplasm of digestive organs

322

2127

1.50

10.74

1.4

1.5

77634.16

58336.55

e6/l

0.32

206

1266

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

418

2.17

10.72

1.6

1.5

75143.00

63592.33

e6/l

0.15

247

Fracture of lower leg, including ankle

330

2217

1.49

10.70

1.5

63246.94

43895.38

e6/l

0.63

198

1307

Vascular disorders of the intestines

281

2.46

10.68

1.5

1.4

87820.17

40787.08

e6/l

0.28

164

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

100

3.58

10.65

1.2

1.6

36356.05

97580.07

e6/l

0.43

Other/unspecified cytomegaloviral diseases

5.39

10.65

1.5

1.4

4925.62

30017.62

e6/l

1.34

Other gastritis (incl. Duodenitis)

172

996

1.74

10.63

1.7

1.4

76799.89

61584.70

e6/l

0.32

102

588

Failure and rejection of transplanted organs and tissues

7.72

10.62

1.3

1.4

16877.78

51680.00

e6/l

—

Malignant neoplasm of breast, HER-positive

180

1040

1.72

10.61

1.4

32568.10

46571.47

e6/l

0.52

103

582

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

4.56

10.53

1.6

1.4

22995.69

142999.97

e6/l

0.64

Basal cell carcinoma

449

2551

1.41

10.52

1.4

1.5

65533.52

57265.83

e6/l

0.23

253

1545

Aortic aneurysm

210

1265

1.64

10.48

1.4

1.5

89703.93

69665.21

e6/l

0.36

122

770

Pneumonia due to Streptococcus pneumoniae

3.73

10.43

1.3

39073.04

124705.40

e6/l

0.68

Open wound of head

347

2342

1.46

10.40

1.5

73374.04

57452.03

e6/l

0.32

214

1415

Disorders of magnesium metabolism

9.12

10.33

1.4

1.3

8309.80

52221.00

e6/l

—

Other infectious diseases

304

2.37

10.32

1.6

1.4

28871.94

74131.80

e6/l

0.97

186

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

5.01

10.31

1.7

1.3

27013.09

139674.07

e6/l

0.43

Benign neoplasm: Stomach

220

2.62

10.29

1.4

1.5

19075.18

62254.91

e6/l

0.81

132

Other malignant neoplasms of skin (=non-melanoma skin cancer)

439

2473

1.41

10.25

1.4

1.5

80253.93

54295.37

e6/l

0.59

258

1482

Erosion of teeth

7.30

10.17

1.7

1.2

15064.13

26104.00

e6/l

—

Parodontitis and operation codes

523

2990

1.36

10.11

1.5

49868.70

55931.25

e6/l

0.24

308

1793

Acquired haemolytic anaemia

4.05

10.10

1.6

1.3

42140.63

126841.68

e6/l

0.40

Other diseases of arteries and capillaries

326

2.30

10.07

1.6

1.4

25476.89

56957.97

e6/l

0.80

201

Cytomegalovirus infection, IBD co-morbidity

4.71

10.06

1.5

1.3

4925.62

49090.00

e6/l

2.43

Fracture of lumbar spine and pelvis

165

959

1.73

10.05

1.5

1.4

43561.61

54771.63

e6/l

0.31

112

571

Acute pancreatitis

148

836

1.78

10.01

1.5

38331.54

57137.01

e6/l

0.56

487

Dermatitis

373

2614

1.43

9.95

1.5

1.4

57643.57

53875.12

e6/l

0.09

222

1566

Mental and behavioural disorders due to opioids

5.18

9.85

1.7

1.3

14800.92

22135.60

e6/l

0.29

Reimbursement for rheumatic diseases

340

2342

1.45

9.84

1.4

1.5

41847.63

49412.50

e6/l

0.37

183

1402

Fracture of shoulder and upper arm

229

1456

1.58

9.81

1.4

1.5

95309.43

47675.36

e6/l

0.96

145

849

Parodontitis or/and operation codes

338

1365

1.48

9.78

1.5

56174.34

61274.75

e6/l

0.11

188

821

Rheumatoid arthritis

230

1329

1.58

9.76

1.5

1.4

42466.71

48199.39

e6/l

0.22

134

784

Clear cell adenocarcinoma of kidney

187

2.73

9.70

1.3

1.4

34208.56

102334.54

e6/l

0.97

109

Disorders of thyroid, IBD co-morbidities

103

373

2.02

9.69

1.6

1.4

26483.55

33958.92

e6/l

0.38

213

Basal cell carcinoma, including avohilmo

452

2578

1.39

9.69

1.4

1.5

65267.27

56960.70

e6/l

0.23

255

1558

Seropositive rheumatoid arthritis, wide

179

1076

1.67

9.68

1.4

45963.94

60794.61

e6/l

0.48

102

630

Benign neoplasm: Transverse colon

430

2.10

9.67

1.4

93397.39

68932.19

e6/l

0.16

250

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

173

1034

1.68

9.57

1.5

1.4

45357.03

62323.03

e6/l

0.54

606

Abdominal and pelvic pain

626

2372

1.33

9.55

1.5

58110.60

61288.79

e6/l

0.09

383

1424

Hydronephrosis

412

2.11

9.53

1.4

37488.10

69875.34

e6/l

0.62

250

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

6.34

9.52

1.3

16002.00

11716.29

e6/l

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

183

2.71

9.49

1.5

29200.52

61541.35

e6/l

0.45

108

Follicular lymphoma

103

3.35

9.47

1.3

1.5

40954.00

92897.86

e6/l

0.33

Need for other prophylactic measures

161

2.83

9.45

1.6

1.4

29067.94

99477.85

e6/l

0.81

Myeloid leukaemia

4.30

9.42

1.6

1.4

83687.36

47824.84

e6/l

0.19

Amputation of ankle bones

3.51

9.41

1.4

116997.67

38153.41

e6/l

0.77

ILD medications: azathioprine

381

2.14

9.39

1.6

1.4

27637.90

83732.49

e6/l

1.34

220

External causes of morbidity and mortality

406

1433

1.42

9.38

1.5

1.4

83550.31

41802.85

e6/l

1.18

248

851

Other nutritional deficiencies

322

2171

1.45

9.34

1.5

81176.96

48918.43

e6/l

0.99

188

1295

Thoracic aortic aneurysm

116

623

1.88

9.31

1.3

1.5

80392.64

56064.11

e6/l

0.35

368

Other and unspecified dermatitis

301

2054

1.47

9.30

1.5

49054.14

52175.55

e6/l

0.08

182

1207

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

124

681

1.83

9.23

1.4

1.5

128914.46

67360.09

e6/l

0.48

395

Exposure to other specified factors

392

2633

1.40

9.19

1.5

89196.78

49736.15

e6/l

1.19

246

1568

Carcinoma in situ of skin of scalp and neck

3.69

9.19

1.7

1.5

48645.93

106633.62

e6/l

0.32

Seropositive rheumatoid arthritis

179

1089

1.65

9.18

1.4

45963.94

52154.15

e6/l

0.18

102

625

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

3.95

9.17

1.3

26195.67

29003.94

e6/l

0.08

Benign neoplasm: Colon, unspecified

195

1216

1.62

9.17

1.5

55673.92

58041.56

e6/l

0.05

115

726

Osteoporosis

179

1040

1.65

9.16

1.5

1.4

82107.24

49137.21

e6/l

0.40

110

609

Osteonecrosis

181

2.69

9.15

1.3

1.4

93591.35

96718.73

e6/l

0.02

105

Rheumatoid arthritis, including avohilmo

243

1595

1.53

9.10

1.5

1.4

48370.38

54486.73

e6/l

0.19

143

926

Systemic sclerosis, icd10

4.65

9.10

1.7

1.2

5658.50

187795.04

e6/l

—

Intracranial and intraspinal abscess and granuloma

6.46

9.06

1.5

23864.20

37139.33

e6/l

—

Weight loss

361

2.16

9.05

1.5

1.4

56379.71

78125.24

e6/l

0.31

217

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

266

2.36

9.02

1.5

1.4

172819.14

93911.45

e6/l

0.37

154

Covid-19 suspected case

468

2.00

9.00

1.7

1.4

139062.00

76010.54

e6/l

0.36

273

Septal defects

119

3.07

8.97

1.9

1.4

70402.27

29081.76

e6/l

0.61

Disorder of lipoprotein metabolism, unspecified

111

595

1.88

8.97

1.5

31612.59

56285.93

e6/l

0.74

354

Other complications of surgical and medical care, not elsewhere classified

279

2.31

8.96

1.5

1.4

14121.87

72952.49

e6/l

1.37

165

Late syphilis

5.31

8.95

1.6

1.4

64246.36

25267.06

e6/l

0.49

Acute pancreatitis (for exclusion)

148

866

1.72

8.91

1.5

38331.54

59906.59

e6/l

0.67

512

Systemic sclerosis

4.40

8.90

1.7

1.3

5909.18

176288.00

e6/l

0.69

Candidiasis

417

2.05

8.86

1.7

1.4

30751.89

75830.00

e6/l

1.14

241

Small cell lung cancer, helper endpoint

108

3.23

8.85

1.2

1.4

28529.04

37687.92

e6/l

0.25

Small cell lung cancer

108

3.23

8.85

1.2

1.4

28529.04

37687.92

e6/l

0.25

Congenital malformations, deformations and chromosomal abnormalities

264

1697

1.49

8.83

1.6

1.4

50044.24

53152.19

e6/l

0.08

157

998

Diagnoses used for exclusion with ILD

186

1159

1.61

8.78

1.5

81003.65

56376.05

e6/l

0.29

111

690

Other/unspecified seropositive rheumatoid arthritis

173

1059

1.64

8.77

1.5

1.4

45357.03

61289.75

e6/l

0.51

621

Benign neoplasm: Sigmoid colon

140

811

1.74

8.75

1.6

1.5

66179.13

58301.17

e6/l

0.10

476

Gangrene, not elsewhere classified

6.30

8.75

1.9

1.2

89472.43

29272.00

e6/l

—

Viral infections characterized by skin and mucous membrane lesions

232

1520

1.53

8.74

1.5

57133.95

58219.76

e6/l

0.01

126

917

Other symptoms and signs involving the circulatory and respiratory systems

157

2.77

8.71

1.6

1.3

60161.00

68028.51

e6/l

0.07

L01XX Other antineoplastic agents

228

2.45

8.67

1.4

152616.45

73106.75

e6/l

0.46

134

Seropositive rheumatoid arthritis, strict definition

518

1.93

8.61

1.5

1.4

41699.28

72336.00

e6/l

0.66

300

Mixed connective tissue disease

164

2.71

8.58

1.3

95296.35

93700.67

e6/l

0.01

Injury, poisoning and certain other consequences of external causes

329

1137

1.45

8.58

1.5

1.4

87208.14

43397.16

e6/l

1.04

204

657

Abnormal findings on diagnostic imaging of other body structures

389

2.07

8.56

1.7

1.4

43088.09

66374.71

e6/l

0.36

221

ILD, hospital admissions 1, main diag only

117

648

1.82

8.56

1.5

1.4

126773.98

66101.30

e6/l

0.63

381

Volvulus

3.41

8.53

1.3

9120.09

38494.67

e6/l

1.06

Asthma, including avohilmo

700

3177

1.28

8.51

1.5

1.4

56069.22

55555.93

e6/l

0.02

418

1910

Other and unspecified types of non-Hodgkin lymphoma, hilmo

171

2.68

8.50

1.5

1.4

33871.71

106074.57

e6/l

0.96

104

Chronic nephritic syndrome

121

3.02

8.50

1.7

1.4

225227.57

79509.78

e6/l

0.29

Statin medication

373

1486

1.41

8.48

1.5

1.4

64756.72

47807.71

e6/l

0.39

231

909

Unspecified fall

301

2076

1.44

8.48

1.5

88190.16

49452.42

e6/l

1.07

180

1235

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

7.75

8.47

1.8

1.1

20620.50

20495.30

e6/l

—

Need for immunization against other single viral diseases

4.39

8.45

1.5

1.4

32298.62

26159.21

e6/l

0.15

Genitourinary diseases

365

1292

1.42

8.41

1.5

1.4

86526.32

55696.55

e6/l

0.64

214

787

Non-Hodgkin lymphoma, all

196

2.55

8.37

1.7

1.4

73192.38

95663.79

e6/l

0.15

121

Other antidepressants

665

2692

1.29

8.36

1.5

69024.09

51480.08

e6/l

0.56

410

1609

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

495

1.93

8.33

1.3

1.5

23366.91

76896.00

e6/l

1.95

293

Azathioprine

400

2.04

8.31

1.6

1.4

27637.90

73924.52

e6/l

1.12

233

Pneumocystosis

4.33

8.27

1.8

1.2

13486.64

30866.48

e6/l

0.85

Childhood asthma (age<16), excluding more controls

6.27

8.22

1.5

1.4

16283.00

17951.25

e6/l

—

Multiple myeloma, excluding all cancers (controls excluding all cancers)

140

2.83

8.20

1.4

1.6

77195.19

74929.99

e6/l

0.01

Poisoning by drugs, medicaments and biological substances

107

584

1.84

8.17

1.4

19477.49

59002.17

e6/l

1.95

350

Obesity related asthma

189

1204

1.58

8.15

1.6

1.5

58017.52

60759.73

e6/l

0.05

111

714

Injury of intra-abdominal organs

4.60

8.14

1.3

1.4

8008.75

31536.65

e6/l

1.37

Malignant neoplasm of other and ill-defined digestive organs

6.80

8.14

1.2

1.3

47858.57

63000.38

e6/l

—

Presence of other functional implants

389

2002

1.38

8.12

1.4

1.5

55076.19

56943.21

e6/l

0.05

213

1201

Nonhereditary hypogammaglobulinemia

6.70

8.12

1.5

1.3

42892.86

8272.50

e6/l

—

Multiple myeloma and malignant plasma cell neoplasms

141

2.81

8.10

1.4

1.6

77936.32

74929.99

e6/l

0.02

Malignant neoplasm of retroperitoneum and peritoneum

7.38

8.07

1.7

1.2

11423.40

44872.50

e6/l

—

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

5.63

8.04

1.3

1.1

18567.00

271658.23

e6/l

—

Diaphragmatic hernia

246

1665

1.48

8.02

1.6

1.5

60090.91

59454.55

e6/l

0.01

139

971

Complications of cardiac and vascular prosthetic devices, implants and grafts

3.43

8.01

1.4

1.3

45294.16

136610.74

e6/l

0.57

Other disorders involving the immune mechanism, not elsewhere classified

3.57

8.00

1.3

26195.67

27953.75

e6/l

0.05

Haemolytic anaemias

3.19

7.99

1.6

1.3

40068.60

142424.21

e6/l

0.70

Diseases of pulp and periapical tissues, including avohilmo

675

2743

1.28

7.98

1.5

1.4

60597.97

52649.56

e6/l

0.25

416

1629

Persons encountering health services for other counselling and medical advice, not elsewhere classified

658

2935

1.28

7.92

1.5

1.4

49425.48

55426.17

e6/l

0.21

414

1736

Duodenal ulcer

534

1.87

7.91

1.3

1.4

37700.03

78362.18

e6/l

1.07

327

Primary biliary cholangitis (PBC)

4.70

7.91

1.3

1.2

4541.43

65496.11

e6/l

—

Malignant neoplasm, without specification of site

138

2.81

7.86

1.4

1.3

63512.22

83481.84

e6/l

0.16

Dissection of aorta

127

2.89

7.85

1.5

1.3

24531.85

43122.61

e6/l

0.45

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

149

2.71

7.82

1.5

1.6

24243.64

85274.54

e6/l

0.78

Zoster [herpes zoster]

124

718

1.74

7.81

1.6

1.4

21713.34

63417.57

e6/l

2.40

425

Psychiatric diseases

668

2619

1.28

7.81

1.5

70072.38

50680.08

e6/l

0.71

430

1527

Benign neoplasm of ovary

303

2.16

7.78

1.3

1.5

84496.66

55715.20

e6/l

0.16

177

Other/unspecified rheumatoid arthritis

495

1.89

7.75

1.4

48635.81

67207.60

e6/l

0.38

292

Diseases of the myoneural junction and muscle

481

1.91

7.74

1.5

1.4

38594.53

75293.14

e6/l

1.10

291

Alcohol dependence

179

1141

1.58

7.74

1.6

1.5

53376.23

61017.70

e6/l

0.15

117

677

Other arthritis (FG)

186

1196

1.56

7.73

1.5

1.4

62633.78

49118.88

e6/l

0.34

116

710

Mental and behavioural disorders due to cannabinoids

6.24

7.72

1.4

8469.00

11530.91

e6/l

—

Abnormal findings in nipple discharge synovial fluid wound secretions

5.12

7.70

1.3

156793.75

25504.67

e6/l

—

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

247

2.29

7.69

1.3

1.5

70886.65

63838.13

e6/l

0.05

147

Thrombocytopenia, unspecified

241

2.31

7.69

1.5

1.4

49302.63

85624.64

e6/l

0.44

140

Other specified/unspecified systemic involvement of connective tissue

145

2.72

7.68

1.2

1.3

116926.87

111693.63

e6/l

0.02

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

186

2.50

7.66

1.3

1.5

12221.97

72432.28

e6/l

1.06

110

Mental and behavioural disorders due to sedatives or hypnotics

134

2.78

7.64

1.4

17834.17

26007.62

e6/l

0.32

Acute posthaemorrhagic anaemia

129

2.84

7.63

1.1

1.3

251478.39

110851.03

e6/l

0.31

Attention to artificial openings

129

2.84

7.62

1.3

23223.23

105345.68

e6/l

0.88

Other viral diseases, not elsewhere classified

510

1.87

7.61

1.4

100767.57

72940.93

e6/l

0.22

303

DVT of lower extremities

141

853

1.66

7.57

1.3

1.5

66549.39

56337.50

e6/l

0.16

496

Dental pulpitis 1

672

2749

1.27

7.57

1.5

1.4

60369.42

52710.88

e6/l

0.23

416

1629

Diabetic neuropathy

525

1.86

7.56

1.6

1.5

46358.97

44329.56

e6/l

0.04

310

Other benign neoplasms of skin

170

1055

1.59

7.56

1.4

1.5

46577.12

54615.64

e6/l

0.24

100

628

Other disorders of veins

221

1482

1.50

7.54

1.5

83475.63

50537.11

e6/l

0.75

126

867

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

262

2.23

7.54

1.6

1.4

12049.43

84916.84

e6/l

1.64

152

Congenital malformations of the urinary system

141

2.72

7.52

1.8

1.3

39381.32

64389.77

e6/l

0.21

Benign neoplasm: Ascending colon

103

573

1.81

7.49

1.8

1.4

35744.97

71919.70

e6/l

1.05

340

Complications of internal orthopaedic prosthetic devices, implants and grafts

158

987

1.61

7.47

1.4

1.5

59231.60

52480.56

e6/l

0.12

582

Abscess of anal and rectal regions

225

2.33

7.47

1.3

1.4

54120.88

69714.79

e6/l

0.15

127

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

4.72

7.46

1.5

1.4

46026.36

58406.27

e6/l

0.10

Angina pectoris

408

2045

1.35

7.45

1.5

73381.24

60501.61

e6/l

0.28

254

1206

Secondary malignant neoplasm of other and unspecified sites

4.14

7.42

1.3

16481.47

32997.66

e6/l

0.64

Other special examinations and investigations of persons without complaint or reported diagnosis

418

1564

1.36

7.40

1.6

1.4

84420.18

49684.56

e6/l

0.94

266

862

Other and unspecified local infections of skin and subcutaneous tissue

297

2.14

7.38

1.8

1.4

27353.00

83027.82

e6/l

1.24

177

Dental pulpitis 4

670

2749

1.27

7.37

1.5

1.4

60511.51

52680.81

e6/l

0.24

415

1630

Benign neoplasm of other and unspecified endocrine glands

271

2.19

7.36

1.7

1.5

37299.42

58740.45

e6/l

0.32

161

Arthropathies in other diseases classified elsewhere

115

2.92

7.35

1.5

1.3

40667.95

107692.86

e6/l

0.65

Other symptoms and signs involving cognitive functions and awareness

317

2142

1.39

7.34

1.5

68994.46

61376.10

e6/l

0.17

187

1262

Syphilis

3.54

7.30

1.6

1.4

47253.53

66078.41

e6/l

0.18

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

3.36

7.28

1.2

1.5

49131.63

121988.29

e6/l

0.38

Other viral diseases

126

746

1.69

7.25

1.4

1.5

82563.51

59812.87

e6/l

0.23

434

Vascular diseases of the intestine

150

2.64

7.23

1.3

1.4

158205.17

42017.06

e6/l

0.36

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

108

616

1.76

7.17

1.5

1.4

37507.60

50156.32

e6/l

0.24

351

Unstable angina pectoris

304

1806

1.40

7.16

1.5

88169.54

59433.92

e6/l

0.51

180

1077

Thyrotoxicosis, other and/or unspecified

104

589

1.77

7.10

1.6

1.5

23389.01

62210.88

e6/l

2.11

354

Pyogenic arthritis

269

2.18

7.10

1.4

1.3

58032.33

82890.63

e6/l

0.33

164

Benign neoplasm of major salivary glands

243

2.24

7.10

1.6

1.5

91061.43

66664.57

e6/l

0.12

140

Thyrotoxicosis

131

791

1.66

7.10

1.5

21332.51

61763.93

e6/l

2.49

465

Rare circulating lymphoid malignancy

112

2.91

7.10

1.7

1.3

54063.13

141709.18

e6/l

0.75

Leiomyoma of uterus

132

437

1.71

7.09

1.4

35520.83

43311.45

e6/l

0.17

248

Spondylopathies in diseases classified elsewhere

4.50

7.02

1.3

1.4

9611.60

28092.48

e6/l

—

Finngen Rheumatological endpoints

549

2433

1.29

7.02

1.5

1.4

68605.73

55846.89

e6/l

0.32

324

1465

Benign neoplasm: Caecum

290

2.12

7.01

1.5

38747.32

74814.83

e6/l

0.47

165

Smoking dependency

251

2.21

7.00

1.3

1.5

28612.42

80156.86

e6/l

1.25

149

Asthma, hospital admissions , main diagnosis only

459

3152

1.31

6.97

1.5

1.4

53583.61

55379.02

e6/l

0.06

275

1880

Postmenopausal atrophic vaginitis

604

0.45

6.93

1.3

1.4

14905.90

40143.51

e6/l

1.37

338

Secondary malignant neoplasm of respiratory and digestive organs

3.91

6.88

1.3

64871.73

40944.66

e6/l

0.37

Phlebitis and thrombophlebitis (not including DVT)

143

891

1.61

6.87

1.4

1.5

76340.09

61788.99

e6/l

0.20

530

Thyrotoxicosis with toxic multinodular goitre

209

2.33

6.85

1.8

1.3

24823.59

87748.82

e6/l

0.92

115

Sulfonylureas

314

1819

1.38

6.85

1.6

1.5

28163.09

65460.13

e6/l

3.62

193

1122

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

169

1095

1.55

6.85

1.5

30026.66

57545.50

e6/l

1.81

104

643

Concussion

266

1626

1.42

6.84

1.5

1.4

66809.59

41491.76

e6/l

0.43

176

936

Mental and behavioural disorders due to tobacco

254

2.19

6.81

1.3

1.5

28612.42

80010.41

e6/l

1.27

151

Other noninfective gastroenteritis and colitis

141

877

1.61

6.79

1.4

1.5

35998.42

51817.64

e6/l

0.46

528

Sequelae of other external causes

161

2.51

6.77

1.6

1.4

33955.04

82099.96

e6/l

0.57

Melanocytic naevi of trunk

235

2.23

6.77

1.5

1.6

78513.50

71709.99

e6/l

0.04

146

Exclusions for E4_PCOS_CONSORTIUM

301

1352

1.40

6.76

1.4

63735.85

43069.91

e6/l

0.47

171

785

Obesity due to excess calories

215

1469

1.47

6.75

1.5

90425.90

47998.71

e6/l

1.00

126

872

Soft tissue disorders

609

2499

1.27

6.75

1.5

1.4

62111.93

51723.23

e6/l

0.27

359

1493

Intracranial injury

339

2422

1.36

6.72

1.5

44432.77

56235.74

e6/l

0.29

219

1448

Other local infections of skin and subcutaneous tissue

322

2.03

6.72

1.8

1.4

26150.90

80838.10

e6/l

1.35

192

Disorders of mineral metabolism

269

2.14

6.70

1.4

10727.69

78493.12

e6/l

1.52

152

Any mental disorder

678

2717

1.25

6.69

1.4

1.5

65800.76

53035.57

e6/l

0.47

438

1595

Injuries to the knee and lower leg

680

3125

1.25

6.68

1.5

76612.14

50144.32

e6/l

1.08

412

1866

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

296

2.08

6.66

1.4

1.5

22143.41

77223.81

e6/l

1.11

170

Other (seronegative) rheumatoid arthritis, wide

120

722

1.67

6.64

1.5

1.4

48914.84

60361.51

e6/l

0.28

435

Acidosis

3.64

6.63

1.6

1.4

21076.07

68232.05

e6/l

0.61

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

193

2.35

6.63

1.3

1.5

45395.75

51913.14

e6/l

0.07

112

Poisoning by medicine

499

1.81

6.62

1.4

16713.20

66578.71

e6/l

2.24

297

Cholelithiasis, broad definition with cholecystitis

534

2870

1.28

6.61

1.5

65868.70

55201.57

e6/l

0.29

329

1708

Essential (haemorrhagic) thrombocythaemia

3.14

6.61

1.3

1.5

143377.21

106962.88

e6/l

0.11

Protozoal diseases

3.22

6.60

1.8

1.3

12090.19

130844.58

e6/l

0.73

Systemic sclerosis (FG)

3.50

6.60

1.7

1.3

5909.18

39898.76

e6/l

0.89

Malignant neoplasm of head and neck

352

1.98

6.59

1.3

1.4

28558.76

90852.09

e6/l

1.70

215

Opening and dilatation of root channel of tooth

128

2.68

6.57

1.5

1.4

23896.77

63747.24

e6/l

0.52

Benign neoplasm: Parotid gland

188

2.36

6.55

1.7

1.6

13597.52

81068.30

e6/l

1.21

112

Persons encountering health services for examination and investigation

414

1564

1.33

6.52

1.5

1.4

67676.33

49684.56

e6/l

0.51

258

862

Other noninfective disorders of lymphatic vessels and lymph nodes

3.04

6.52

1.7

1.3

33032.41

107491.18

e6/l

0.51

Open wound of ankle and foot

292

2.07

6.51

1.6

1.4

34849.97

105682.85

e6/l

1.27

175

Anorexia

4.92

6.48

1.4

1.2

33285.00

46777.33

e6/l

—

Melanocytic naevi

107

628

1.71

6.48

1.5

52095.02

56266.64

e6/l

0.05

364

Benign neoplasm: Descending colon

183

2.37

6.47

1.9

1.5

18580.72

80987.50

e6/l

1.05

108

Alcohol-induced chronic pancreatitis

221

2.24

6.46

1.7

1.5

34331.88

70666.78

e6/l

0.79

134

Other renal tubulo-interstitial diseases

3.97

6.46

1.4

1.2

10717.64

148050.67

e6/l

0.61

Sequelae of cerebrovascular disease

277

1751

1.39

6.45

1.4

1.5

57574.48

64120.60

e6/l

0.15

176

1043

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

307

2.04

6.43

1.4

1.5

22143.41

74987.08

e6/l

1.11

178

Lung diseases due to external agents

114

684

1.68

6.41

1.5

1.4

115299.14

72153.80

e6/l

0.35

407

Abnormal weight loss

337

1.98

6.31

1.5

1.4

59654.78

80993.47

e6/l

0.27

200

Childhood asthma (age<16)

4.77

6.30

1.5

1.4

16283.00

13578.64

e6/l

—

Drug-induced hypoglycaemia without coma

3.92

6.30

1.6

1.3

75007.30

38482.48

e6/l

—

Autoimmune diseases related-to ILD

468

3211

1.28

6.28

1.5

55304.44

52673.44

e6/l

0.06

276

1931

Other diseases of urinary system

617

2779

1.25

6.24

1.5

72951.38

53716.29

e6/l

0.63

353

1706

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

4.77

6.24

1.6

1.1

13766.67

21613.75

e6/l

—

Congenital malformations of aortic and mitral valves

2.89

6.22

1.5

1.4

75115.00

21830.38

e6/l

0.76

Other symptoms and signs involving the digestive system and abdomen

518

1.77

6.18

1.4

60543.00

70948.33

e6/l

0.14

303

Unspecified misadventure during surgical and medical care

175

2.37

6.16

1.7

1.4

15852.00

102626.08

e6/l

1.42

106

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

3.42

6.15

1.4

58558.82

45562.83

e6/l

0.16

Congenital malformations of great arteries

4.98

6.08

1.5

1.4

24210.00

22122.50

e6/l

—

Carcinoma in situ of skin of lower limb, including hip

3.67

6.08

1.6

1.5

20158.30

158456.23

e6/l

—

Morphin

3.67

6.08

1.7

1.4

314313.33

34683.15

e6/l

0.45

Diseases of oral cavity, salivary glands and jaws

584

2387

1.26

6.07

1.5

1.4

65704.79

54852.34

e6/l

0.30

348

1438

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

204

849

1.47

6.07

1.5

57303.59

64981.51

e6/l

0.15

126

522

Delirium, not induced by alcohol and other psychoactive substances

558

1.73

6.07

1.5

1.4

78525.84

68327.64

e6/l

0.11

331

Sleep disorders (combined)

566

2961

1.25

6.05

1.5

1.4

83770.79

49621.37

e6/l

1.31

340

1771

Retinal vascular disorders

582

1.72

6.04

1.3

1.5

61959.59

59233.67

e6/l

0.03

348

Other and unspecified acquired haemolytic anaemias

4.98

6.03

1.8

1.2

15962.50

38339.50

e6/l

—

Adenocarcinoma and ductal carcinoma of pancreas

141

2.53

5.98

1.2

1.4

36356.05

68867.71

e6/l

0.50

Cystic kidney disease

3.02

5.98

1.7

1.4

53260.78

22766.87

e6/l

0.34

Cholecystitis

105

629

1.68

5.96

1.4

72878.52

65602.56

e6/l

0.09

362

Malignant neoplasm of breast, HER-negative

106

637

1.67

5.91

1.4

43812.13

57816.45

e6/l

0.22

366

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

387

1.87

5.91

1.4

1.5

21958.89

64236.30

e6/l

1.15

232

Carcinoma in situ of skin of other and unspecified parts of face

410

1.85

5.89

1.7

1.4

13059.00

71192.39

e6/l

2.35

246

Benign neoplasm: Rectum

127

801

1.60

5.89

1.5

55784.71

68498.33

e6/l

0.24

475

Benign neoplasm: Adrenal gland

160

2.39

5.88

1.8

1.6

11908.74

84791.70

e6/l

1.11

Osteonecrosis due to drugs

4.29

5.87

1.3

5782.78

41071.45

e6/l

—

Melanoma in situ

119

2.64

5.83

1.7

1.6

101392.59

79768.19

e6/l

0.12

Dipeptidyl peptidase 4 (DPP-4) inhibitors

536

1.73

5.81

1.8

1.5

23948.26

77739.54

e6/l

1.89

325

General examination and investigation of persons without complaint and reported diagnosis

384

1555

1.32

5.79

1.5

1.4

47101.73

49537.44

e6/l

0.08

263

857

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

3.11

5.79

1.5

13358.11

118823.70

e6/l

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

5.16

5.79

1.8

1.3

20620.50

44514.19

e6/l

—

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

131

2.54

5.78

1.5

1.6

28249.55

91743.32

e6/l

0.68

Other chondrocalcinosis

4.03

5.77

1.2

1.4

167834.44

213732.73

e6/l

—

Embolic stroke with flimmer

2.95

5.75

1.3

1.2

55975.07

68467.57

e6/l

0.14

IgA nephropathy (IgA glomerulonephritis)

3.39

5.75

1.4

21308.13

29032.67

e6/l

0.26

103

2.78

5.74

1.3

49398.23

133357.12

e6/l

0.56

Dependence on enabling machines and devices, not elsewhere classified

5.10

5.74

1.4

1.2

2641.67

27638.46

e6/l

—

Diseases of the eye and adnexa

417

1607

1.30

5.72

1.4

1.5

78794.32

48196.89

e6/l

0.80

257

988

Obesity and other hyperalimentation

288

2113

1.35

5.72

1.6

1.5

76817.73

50114.94

e6/l

0.77

171

1259

Degeneration of macula and posterior pole

353

2218

1.32

5.70

1.4

64669.91

56512.99

e6/l

0.13

207

1330

Discitis, unspecified

3.78

5.68

1.3

54167.33

28583.54

e6/l

—

Other and unspecified coagulation defects

2.85

5.68

1.7

1.3

256742.28

39507.92

e6/l

0.40

Arterial embolism and thrombosis

247

2.09

5.67

1.3

1.4

14757.73

37150.27

e6/l

1.02

153

Tubulo-interstitial nephritis, not specified as acute or chronic

221

2.14

5.63

1.5

1.4

30889.96

61787.25

e6/l

0.52

138

Obesity

286

2105

1.35

5.60

1.6

1.5

77241.36

50336.20

e6/l

0.77

170

1253

Other specified/unspecified arthritis

158

1058

1.50

5.59

1.5

1.4

62652.73

48986.78

e6/l

0.29

632

Neuroendocrine tumor and carcinoma of small intestine

3.91

5.58

1.3

1.4

16002.00

32982.78

e6/l

—

Left ventricular outflow tract obstruction, narrow definition

116

2.61

5.56

1.5

71740.53

29733.67

e6/l

0.57

Retinal vascular occlusion

574

1.69

5.54

1.4

1.5

63955.64

60049.35

e6/l

0.05

343

Pain (limb, back, neck, head abdominally)

467

1836

1.28

5.53

1.5

1.4

70343.62

56794.20

e6/l

0.32

275

1109

Intestinal malabsorption

105

2.69

5.51

2.0

1.2

7123.71

26062.46

e6/l

2.23

Other and unspecified myopathies

354

1.88

5.51

1.5

1.4

40152.71

78765.62

e6/l

0.84

216

Personality disorders, excluding more controls

536

1.70

5.51

1.6

1.4

19144.39

53636.79

e6/l

1.30

303

Gingivitis and periodontal diseases

563

2335

1.25

5.51

1.5

1.4

60504.26

53393.48

e6/l

0.19

327

1402

Abnormal spermatozoa

687

0.42

5.50

1.6

1.5

51267.26

62186.64

e6/l

0.19

409

Chronic diseases of tonsils and adenoids

220

1939

0.72

5.50

1.5

1.4

50954.25

43634.66

e6/l

0.17

128

1164

Disorders of calcium metabolism

204

2.18

5.48

1.3

1.4

10569.89

93460.52

e6/l

1.41

118

Carcinoma in situ of skin

362

1.87

5.48

1.4

27182.83

76463.26

e6/l

1.28

215

Portal vein thrombosis

4.03

5.47

1.5

1.3

5243.75

31576.43

e6/l

—

Other and unspecified vascular occlusions

427

1.80

5.47

1.4

74846.40

58628.13

e6/l

0.18

262

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

333

1.90

5.46

1.4

44184.68

77355.01

e6/l

0.38

191

Other disorders of urethra and urinary system

403

2351

1.29

5.46

1.4

1.5

81696.55

51378.00

e6/l

0.78

235

1428

Methotrexate

464

1.75

5.44

1.4

54331.86

74053.60

e6/l

0.34

267

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

201

839

1.44

5.41

1.5

57727.84

65762.62

e6/l

0.16

124

515

Fall involving bed

124

2.55

5.41

1.2

1.3

20297.59

85945.90

e6/l

0.78

Sequelae of injuries of neck and trunk

3.05

5.39

1.6

1.4

35678.46

49107.74

e6/l

0.22

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

3.75

5.37

1.4

41140.11

26758.46

e6/l

—

Myeloproliferative diseases

336

1.89

5.36

1.3

1.4

113387.50

92817.69

e6/l

0.14

198

Carcinoma in situ of other and unspecified digestive organs

3.23

5.34

1.5

1.4

25932.78

147971.97

e6/l

—

Other menopausal disorders

540

0.50

5.34

1.4

98396.57

41883.23

e6/l

0.27

306

Gastro-oesophageal reflux disease

383

2643

1.29

5.30

1.5

1.4

78772.07

51417.62

e6/l

0.63

241

1594

Fitting and adjustment of other devices

220

1473

1.39

5.27

1.4

69297.29

59779.53

e6/l

0.14

164

883

Other diseases of pancreas

296

1.94

5.26

1.4

20996.91

93017.90

e6/l

1.72

175

Suicide or other Intentional self-harm

105

651

1.62

5.25

1.5

1.4

39074.93

63294.16

e6/l

0.52

384

Carcinoma in situ of skin of upper limb, including shoulder

3.19

5.22

1.5

141977.83

121832.17

e6/l

—

Benign neoplasm: Duodenum

3.18

5.21

1.4

1.5

154261.62

136393.97

e6/l

0.05

Carcinoma in situ of breast, intraductal

120

2.51

5.20

1.2

1.5

139675.64

80872.28

e6/l

0.26

Abnormalities of gait and mobility

532

1.69

5.17

1.4

153513.18

57539.76

e6/l

0.61

317

Tuberculosis, IBD comorbidity

355

1.85

5.16

1.5

1.4

59726.79

59609.04

e6/l

0.00

214

Benign neoplasm: Rectum, anus and anal canal

140

932

1.51

5.15

1.5

52302.65

63262.25

e6/l

0.23

549

Use of disulfiram, acamprosate or naltrexone

216

2.10

5.14

1.8

1.5

29821.43

53030.09

e6/l

0.37

126

Benign neoplasm of urinary organs

109

2.59

5.14

1.1

1.6

106181.94

90254.27

e6/l

0.08

Procreative management

113

601

1.59

5.14

1.4

35363.05

51282.74

e6/l

0.40

352

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

384

1.81

5.13

1.4

1.5

229207.24

67530.07

e6/l

0.73

229

Shock, not elsewhere classified

4.32

5.13

1.5

1.2

3396.43

46822.71

e6/l

—

N06DA Anticholinesterases

142

1696

0.67

5.13

1.3

1.5

45980.02

64863.48

e6/l

0.64

999

Use of anticholinesterases

142

1696

0.67

5.13

1.3

1.5

45980.02

64863.48

e6/l

0.64

999

Polyarteritis nodosa and related conditions

4.28

5.12

1.5

1.4

132387.57

69581.18

e6/l

—

Umbilical hernia

160

1096

1.47

5.10

1.4

1.5

45848.30

59133.44

e6/l

0.42

662

Disorders of skin appendages

212

1527

1.39

5.09

1.5

26007.05

53735.76

e6/l

2.43

133

901

Alcohol withdrawal state with delirium

258

2.00

5.08

1.5

78279.97

50091.98

e6/l

0.19

162

Filling of root of tooth

3.11

5.08

1.5

1.3

34437.85

23829.77

e6/l

0.26

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

550

1.66

5.08

1.6

1.4

52120.42

64934.45

e6/l

0.26

320

Other systemic involvement of connective tissue (FG)

154

1041

1.48

5.07

1.4

53303.39

52422.71

e6/l

0.01

601

Other and unspecified drugs and medicaments

265

1.98

5.07

1.6

1.4

12661.36

96384.82

e6/l

1.88

154

Familial hypercholesterolemia

115

738

1.57

5.02

1.6

1.4

107840.67

60968.55

e6/l

0.41

433

Postprocedural disorders of digestive system, not elsewhere classified

2.66

5.00

1.3

1.4

19811.06

113074.00

e6/l

0.74

Dizziness and giddiness

442

2863

1.26

4.99

1.4

1.5

50740.88

56626.79

e6/l

0.23

284

1701

Actinic keratosis

290

2092

1.32

4.95

1.5

83319.05

55746.76

e6/l

0.41

162

1258

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

108

685

1.58

4.93

1.5

1.4

37507.60

61031.43

e6/l

0.53

404

Epilepsy

185

1307

1.42

4.93

1.4

1.5

74399.12

39805.31

e6/l

0.91

131

750

Other coagulation defects

187

2.16

4.91

1.5

1.3

182011.89

66730.44

e6/l

0.30

105

Other and unspecified nonorganic psychotic disorders

420

1.74

4.86

1.6

1.4

32962.15

65378.80

e6/l

0.61

245

Use of rivastigmine

786

0.49

4.85

1.3

1.4

23560.15

66391.55

e6/l

2.24

474

Benign neoplasm: Rectosigmoid junction

101

2.60

4.82

1.3

1.6

84594.55

92016.74

e6/l

0.03

ILD-related respiratory insufficiency

144

2.33

4.81

1.5

1.3

226213.83

101180.44

e6/l

0.47

Infection of intervertebral disc (pyogenic)

3.66

4.81

2.1

1.4

205850.00

24349.31

e6/l

—

Benign lipomatous neoplasm of other sites/unspecified

216

2.05

4.77

1.4

1.5

36754.83

63165.08

e6/l

0.34

129

Disorders of parathyroid gland

131

864

1.50

4.76

1.5

1.4

72469.40

44980.31

e6/l

0.31

498

303

2191

1.31

4.76

1.5

83231.50

54449.03

e6/l

0.46

169

1312

Occupational exposure to risk-factors

120

2.45

4.74

1.4

74837.50

78888.03

e6/l

0.03

Fracture of foot, except ankle

108

693

1.56

4.72

1.5

1.4

35108.20

56071.84

e6/l

0.49

401

Triptan medication for migraine, single purchase ok

169

1616

0.71

4.71

1.5

1.4

35075.79

47280.70

e6/l

0.64

104

935

Migraine, single triptan purchase ok & required. ICD-code if available is included

169

1616

0.71

4.71

1.5

1.4

35075.79

47280.70

e6/l

0.64

104

935

Malignant neoplasm of other connective and soft tissue

2.75

4.71

1.2

1.3

24080.00

112702.48

e6/l

0.62

Other systemic involvement of connective tissue

157

1090

1.45

4.71

1.4

1.5

52049.77

59407.73

e6/l

0.13

651

Other neurological diseases

461

2994

1.24

4.70

1.4

1.5

72084.47

54899.24

e6/l

0.54

287

1792

Skin changes due to chronic exposure to nonionizing radiation

293

2126

1.31

4.69

1.5

84536.88

55494.31

e6/l

0.45

165

1275

Other necrotizing vasculopathies

280

1.91

4.69

1.6

1.5

30088.97

89396.41

e6/l

0.92

165

Glaucoma secondary to other eye disorders

152

2.26

4.68

1.3

17088.72

32508.85

e6/l

0.68

Disorders of other endocrine glands

215

1551

1.37

4.68

1.5

90839.15

46030.76

e6/l

0.74

142

899

Right bundle-branch block

2.78

4.62

1.8

1.2

38412.75

90565.07

e6/l

0.77

Urticaria and erythema

157

1094

1.44

4.61

1.5

75904.76

51118.41

e6/l

0.38

638

Other functional intestinal disorders

263

1898

1.32

4.59

1.5

50260.08

54809.30

e6/l

0.10

165

1125

Respiratory tuberculosis, confirmed

2.85

4.58

1.3

1.2

33850.33

28127.16

e6/l

0.07

Other inflammatory liver diseases

186

2.11

4.57

1.8

1.3

45219.60

112002.32

e6/l

0.69

107

Spondylopathies

501

2477

1.23

4.57

1.4

1.5

72604.96

54750.00

e6/l

0.54

302

1477

Other and unspecified effects of external causes

111

723

1.54

4.55

1.6

1.4

19307.21

57684.72

e6/l

2.14

427

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

104

2.52

4.54

1.7

1.5

16940.06

106453.87

e6/l

0.81

Carcinoma in situ of skin of scalp and neck

123

2.41

4.54

1.7

1.4

48645.93

54579.88

e6/l

0.07

Hernia of abdominal wall

271

2069

1.31

4.53

1.4

1.5

38024.82

59527.86

e6/l

1.53

164

1243

Vitamin deficiency

148

2.25

4.51

1.2

1.3

92399.47

71965.99

e6/l

0.08

Vitamin deficiency, wide

148

2.25

4.51

1.2

1.3

92399.47

71965.99

e6/l

0.08

Obesity, other/unspecified

139

951

1.47

4.50

1.7

1.4

60830.91

44454.48

e6/l

0.35

562

Alcohol abuse, main dg, excluding more controls

468

1.67

4.50

1.4

52151.79

61670.81

e6/l

0.11

270

Myeloid leukaemia

2.62

4.50

1.6

1.3

83687.36

26420.71

e6/l

0.37

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

127

1521

0.68

4.49

1.5

42648.28

53442.84

e6/l

0.27

881

Other diseases of anus and rectum

185

1334

1.39

4.48

1.5

59714.67

51375.02

e6/l

0.13

117

790

Benign neoplasm: Small intestine

105

2.50

4.48

1.5

1.6

125662.56

88239.15

e6/l

0.17

Assault

263

1.91

4.47

1.6

1.4

50048.85

57107.40

e6/l

0.06

154

Exposure to other and unspecified inanimate mechanical forces

155

2.21

4.46

1.8

1.4

42923.73

100914.21

e6/l

0.60

Tuberculosis, wide

374

1.75

4.40

1.5

1.4

59726.79

58967.53

e6/l

0.01

223

Dental pulpitis 2

479

1990

1.23

4.39

1.5

1.4

69779.03

51484.62

e6/l

0.46

281

1200

Neovascular glaucoma

150

2.23

4.39

1.3

1.4

17088.72

72353.48

e6/l

0.75

Benign neoplasm of mouth and pharynx

251

1.92

4.38

1.5

73616.52

61650.91

e6/l

0.08

150

Malignant neoplasm of small intestine

2.78

4.38

1.2

1.4

12117.57

24414.19

e6/l

—

Cerebral palsy and other paralytic syndromes

382

1.74

4.36

1.7

1.4

81070.73

72743.07

e6/l

0.06

235

Dermatophytosis

519

1.63

4.35

1.4

67172.48

70924.17

e6/l

0.04

306

Injuries to the elbow and forearm

344

2456

1.27

4.35

1.4

1.5

56986.41

47774.19

e6/l

0.31

202

1451

Transient ischemic attack

361

2376

1.26

4.34

1.4

1.5

62879.49

59043.95

e6/l

0.09

234

1414

Neurological diseases, wide definition

129

429

1.51

4.34

1.5

1.4

136531.82

35390.89

e6/l

1.05

250

Respiratory conditions due to other external agents

2.83

4.32

1.4

1.3

38750.08

123955.91

e6/l

0.50

Parodontitis, under 40 years

2.96

4.27

1.4

1.6

18787.91

12870.06

e6/l

0.19

Other diseases of stomach and duodenum

247

1.92

4.26

1.6

1.4

55189.96

99875.23

e6/l

0.55

150

Asthma mixed form (mode)

3.05

4.24

1.2

1.3

40696.67

10217.97

e6/l

0.97

Noninfectious colitis NAS

439

1.67

4.21

1.3

1.5

47325.82

58325.58

e6/l

0.15

266

Persons encountering health services in other circumstances

182

1324

1.38

4.20

1.5

37585.57

50798.50

e6/l

0.65

127

764

Cholelithiasis

492

2837

1.22

4.20

1.5

65183.64

55458.39

e6/l

0.24

308

1689

Dental pulpitis 2, only avohilmo

489

2047

1.22

4.18

1.5

1.4

63543.31

54871.21

e6/l

0.20

280

1241

Parodontitis, under 40 years, or operation codes

2.91

4.16

1.4

1.6

18787.91

12870.06

e6/l

0.19

Sleep apnoea

519

2911

1.21

4.16

1.5

81646.03

49359.76

e6/l

1.18

320

1735

Other diseases of oesophagus

403

1.70

4.15

1.9

1.4

22840.39

77602.52

e6/l

1.72

248

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

2.51

4.15

1.9

1.5

32751.28

93580.54

e6/l

0.47

Abdominal aortic aneurysm (AAA)

584

1.57

4.14

1.4

82630.54

61605.58

e6/l

0.35

361

Carbimazole or st.post thyroidectomy, condition for graves disease

582

1.57

4.10

1.5

1.4

23505.43

60973.16

e6/l

1.63

342

Respiratory tuberculosis, bacteriologically and histologically confirmed

2.67

4.09

1.3

1.2

33850.33

42941.51

e6/l

0.11

Dental caries 3

545

2310

1.21

4.07

1.5

1.4

70585.41

50628.99

e6/l

0.50

312

1402

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

142

2.20

4.05

1.4

13503.24

71112.84

e6/l

0.73

Carcinoma in situ of other and unspecified sites

117

2.34

4.03

1.4

1.6

27750.82

81090.08

e6/l

0.54

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

2.98

4.03

1.2

1.6

49213.27

47639.06

e6/l

0.01

Haemangioma and lymphangioma, any site

169

2.08

4.01

1.5

1.6

104612.13

86792.14

e6/l

0.08

Symptoms and signs involving the skin and subcutaneous tissue

363

2907

1.24

4.00

1.5

73143.18

52307.34

e6/l

0.61

234

1727

Dental caries 1

526

2226

1.21

4.00

1.5

1.4

73038.40

53648.78

e6/l

0.45

298

1352

Primary gonarthrosis, bilateral

216

2489

0.76

4.00

1.5

1.4

76738.23

54526.87

e6/l

0.51

124

1478

Gonarthrosis, primary, with knee surgery

253

2667

0.77

3.99

1.5

1.4

43134.99

57333.25

e6/l

0.75

153

1597

Follow-up examination after treatment for conditions other than malignant neoplasms

237

1178

1.32

3.95

1.5

1.4

70086.79

49068.71

e6/l

0.43

151

630

Dental caries, including avohilmo

525

2225

1.21

3.94

1.5

1.4

73270.52

53678.13

e6/l

0.46

297

1351

Adult respiratory distress syndrome

3.33

3.94

1.4

1.3

17116.00

29912.14

e6/l

—

Vitamin D deficiency

3.68

3.93

1.0

1.2

3505.17

32950.56

e6/l

—

Fall on and from stairs and steps

135

946

1.43

3.93

1.6

1.4

98636.17

47131.21

e6/l

0.54

569

Noninfective enteritis and colitis

230

1752

1.31

3.93

1.4

1.5

61276.37

49545.88

e6/l

0.17

133

1043

Localized swelling, mass and lump of skin and subcutaneous tissue

171

1248

1.37

3.93

1.4

1.5

93162.53

56568.57

e6/l

0.63

116

727

Arterial embolism and thrombosis of lower extremity artery

138

2.20

3.91

1.4

20523.74

43182.59

e6/l

0.52

Special screening examination for neoplasms

178

2.04

3.90

1.4

192006.57

70373.23

e6/l

0.33

Sequelae of injuries of head

138

2.19

3.90

1.4

26603.00

80233.01

e6/l

0.87

Other specified disorders of kidney and ureter

2.47

3.90

1.2

1.3

27227.27

104157.87

e6/l

0.60

Acute upper respiratory infections of multiple and unspecified sites

365

2201

1.24

3.89

1.5

1.4

66353.41

51091.77

e6/l

0.43

243

1286

Renal tubulo-interstitial disorders in diseases classified elsewhere

3.89

3.83

1.5

1.2

127464.00

39216.29

e6/l

—

Viral and other specified intestinal infections

432

1.63

3.83

1.3

1.4

17014.98

63958.39

e6/l

1.69

266

Corns and callosities

235

1.89

3.83

1.5

1.4

17170.36

78902.85

e6/l

1.46

136

Coronary angioplasty

270

1615

1.29

3.82

1.5

50844.78

66082.65

e6/l

0.55

167

967

Right hemicolectomy

257

1.85

3.82

1.3

1.4

72005.93

76740.39

e6/l

0.03

158

Dental caries 1 and operation codes

565

2428

1.20

3.81

1.5

1.4

65482.55

52332.37

e6/l

0.35

329

1473

Other reaction to severe stress, and adjustment disorders

124

860

1.44

3.81

1.5

1.4

61312.79

50254.21

e6/l

0.14

488

Dementia in Alzheimer disease

964

0.63

3.79

1.3

1.5

55474.67

56477.45

e6/l

0.01

579

Other and unspecified injuries of head

180

2.02

3.79

1.6

1.4

257366.81

42329.95

e6/l

0.64

106

Hyperparathyroidism

114

771

1.47

3.77

1.4

74952.90

48451.62

e6/l

0.25

450

Unspecific neurodegenerative disorder

204

1854

0.76

3.76

1.3

1.5

58172.13

69560.41

e6/l

0.27

127

1090

Idiopathic pulmonary fibrosis

393

1.67

3.74

1.7

1.4

141367.50

66180.25

e6/l

0.70

236

Degeneration of the brain due to alcohol

2.54

3.74

1.4

23252.25

19812.35

e6/l

0.11

Supplementary factors related to causes of morbidity and mortality classified elsewhere

150

1081

1.39

3.74

1.5

98645.32

57332.82

e6/l

0.97

105

641

Alcohol abuse, main dg

493

1.59

3.73

1.4

1.5

52151.79

62821.42

e6/l

0.13

293

Lichen simplex chronicus and prurigo

223

1.90

3.73

1.5

1.3

42115.52

99416.04

e6/l

0.77

127

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

103

2.36

3.68

1.4

1.5

184771.53

87571.25

e6/l

0.29

Carcinoma in situ of skin of ear and external auricular canal

3.18

3.68

1.6

1.5

51788.38

13602.27

e6/l

—

Type of accident

139

992

1.41

3.67

1.5

92722.62

58779.07

e6/l

0.76

589

Focal epilepsy

115

793

1.45

3.67

1.4

1.5

82682.34

57868.25

e6/l

0.37

468

Benign neoplasm of other and ill-defined parts of digestive system

105

712

1.48

3.66

1.6

1.4

46212.55

63302.28

e6/l

0.35

421

Haemangioma, any site

162

2.05

3.65

1.4

1.6

111608.52

91297.15

e6/l

0.08

Carcinoma in situ, bladder

110

2.30

3.64

1.4

1.5

17366.80

78022.59

e6/l

0.61

Behavioural syndromes associated with physiological disturbances and physical factors

118

820

1.44

3.60

1.5

20963.33

54573.41

e6/l

2.05

495

Adenocarcinoma of pancreas

117

2.26

3.60

1.2

1.3

49131.63

56605.82

e6/l

0.09

Personal history of other diseases and conditions

162

2.03

3.60

1.6

1.4

15246.67

116041.80

e6/l

1.22

Other metabolic disorders

314

1.73

3.57

1.6

1.4

28095.87

69916.84

e6/l

0.86

182

Dislocation, sprain and strain of joints and ligaments of thorax

2.59

3.56

1.7

1.4

62879.73

24782.00

e6/l

0.40

Follicular lymphoma, hilmo

171

2.01

3.55

1.3

40954.00

128670.68

e6/l

0.84

103

Malignant neoplasm of oesophagus

105

2.32

3.55

1.4

77526.88

22020.52

e6/l

0.33

Emotionally unstable personality disorder

157

2.04

3.54

2.0

1.4

17459.10

62453.62

e6/l

0.81

Unspecified jaundice

206

1.91

3.54

1.4

1.3

23729.59

81361.32

e6/l

0.89

125

Gonarthrosis,primary

416

3160

0.83

3.54

1.5

68312.59

56202.93

e6/l

0.41

246

1907

Dental caries 2 and operation codes, only avohilmo

201

1636

0.76

3.53

1.6

1.5

25739.84

62542.12

e6/l

2.93

112

981

Parodontitis, under 40 years and operation codes

2.81

3.52

1.3

1.6

20496.70

13150.97

e6/l

—

Parodontitis, operation under 40 years and operation codes

2.81

3.52

1.3

1.6

20496.70

13150.97

e6/l

—

Benign neoplasm: Skin of other and unspecified parts of face

286

1.76

3.51

1.5

1.6

51129.85

56076.46

e6/l

0.06

170

Malignant melanoma

654

1.49

3.50

1.5

68497.96

69425.26

e6/l

0.01

390

Monoplegia

3.39

3.49

1.8

1.4

37970.00

25396.90

e6/l

—

Schizophrenia or delusion, excluding more controls

125

877

1.42

3.49

1.5

1.4

45843.29

45936.62

e6/l

0.00

501

Fracture of skull and facial bones

104

712

1.47

3.47

1.4

53119.32

54179.18

e6/l

0.01

417

Palmar fascial fibromatosis [Dupuytren]

122

862

1.42

3.46

1.5

1.4

85424.78

58729.38

e6/l

0.38

501

Multiple myeloma and malignant plasma cell neoplasms

208

1.90

3.46

1.4

77936.32

91521.22

e6/l

0.10

127

Injuries to unspecified part of trunk, limb or body region

325

1.70

3.46

1.8

1.4

69667.38

65482.69

e6/l

0.04

198

Benign neoplasm of eye and adnexa

229

1.84

3.46

1.5

1.6

36508.29

67170.41

e6/l

0.49

140

Extreme obesity with alveolar hypoventilation

119

2.21

3.46

1.4

27372.76

86274.60

e6/l

0.53

Acute nephritic syndrome

2.79

3.43

1.8

1.3

2669.50

33203.00

e6/l

—

Other benign neoplasms of connective and other soft tissue

201

1.90

3.43

1.5

65047.26

69473.03

e6/l

0.04

121

Infections with a predominantly sexual mode of transmission

583

1.51

3.43

1.4

32080.53

58993.21

e6/l

0.84

339

Other diseases of liver

576

1.52

3.43

1.7

1.4

41747.68

66138.95

e6/l

0.51

343

Collagenous colitis

296

1.73

3.42

1.5

1.4

20110.35

66678.77

e6/l

1.29

170

Squamous cell neoplasms and carcinomas of the skin

674

1.48

3.42

1.5

115429.34

67659.85

e6/l

0.27

409

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

272

2116

1.26

3.42

1.5

101629.55

47327.20

e6/l

1.06

165

1286

Degeneration of nervous system due to alcohol

2.42

3.42

1.4

23252.25

18869.47

e6/l

0.14

Retinal detachments and breaks

224

1740

1.29

3.41

1.4

1.5

85286.89

57321.00

e6/l

0.65

131

1030

Oesophageal obstruction

140

2.10

3.39

1.4

14357.00

122391.37

e6/l

1.37

Respiratory tuberculosis, confirmed and not-confirmed

275

1.76

3.39

1.4

30283.04

71046.98

e6/l

0.83

166

Respiratory tuberculosis

275

1.76

3.39

1.4

30283.04

71046.98

e6/l

0.83

166

Personality disorders

610

1.50

3.37

1.6

1.4

19144.39

61658.34

e6/l

1.95

355

TMD related pain

3.12

3.37

1.4

1.2

21532.86

51755.33

e6/l

—

Diseases of the musculoskeletal system and connective tissue

288

1145

1.26

3.35

1.5

1.4

71816.59

54053.32

e6/l

0.31

175

696

Polycythaemia vera

2.34

3.35

1.1

1.6

21145.56

95326.80

e6/l

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Erythrocytes [#/volume] in Pleural fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS